JPH08112063A - Whey protein hydrolyzate having excellent flavor and its production - Google Patents

Whey protein hydrolyzate having excellent flavor and its production

Info

Publication number
JPH08112063A
JPH08112063A JP6274303A JP27430394A JPH08112063A JP H08112063 A JPH08112063 A JP H08112063A JP 6274303 A JP6274303 A JP 6274303A JP 27430394 A JP27430394 A JP 27430394A JP H08112063 A JPH08112063 A JP H08112063A
Authority
JP
Japan
Prior art keywords
whey protein
amount
hydrolyzate
weight
lysine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP6274303A
Other languages
Japanese (ja)
Other versions
JP2959747B2 (en
Inventor
Seiichi Shimamura
誠一 島村
Yoshitaka Tamura
吉隆 田村
Hitoshi Saito
仁志 齋藤
Naoko Isomura
奈生子 磯村
Yoko Akazome
陽子 赤染
Hiroshi Ochi
浩 越智
Mihoko Kawamoto
美穂子 河本
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Morinaga Milk Industry Co Ltd
Original Assignee
Morinaga Milk Industry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to JP6274303A priority Critical patent/JP2959747B2/en
Application filed by Morinaga Milk Industry Co Ltd filed Critical Morinaga Milk Industry Co Ltd
Priority to CA002202633A priority patent/CA2202633C/en
Priority to EP95934302A priority patent/EP0799577B1/en
Priority to US08/817,095 priority patent/US5952193A/en
Priority to AU36738/95A priority patent/AU692612B2/en
Priority to DE69523791T priority patent/DE69523791T2/en
Priority to NZ294046A priority patent/NZ294046A/en
Priority to DK95934302T priority patent/DK0799577T3/en
Priority to PCT/JP1995/002109 priority patent/WO1996011584A1/en
Publication of JPH08112063A publication Critical patent/JPH08112063A/en
Priority to AU63603/98A priority patent/AU701507B2/en
Priority to US09/316,957 priority patent/US6395508B1/en
Application granted granted Critical
Publication of JP2959747B2 publication Critical patent/JP2959747B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

PURPOSE: To obtain a whey protein hydrolyzate having excellent flavor usable as a raw material for a resource of protein to infancy, early childhood and nursing mothers or a sick person having lowered immunological function aiming at prevention of allergies of infancy and early childhood having immature digestive ability or an aged person, a sick person or an allergy patient having lowered digestive ability. CONSTITUTION: This whey protein hydrolyzate having excellent flavor is a hydrolyzate of whey protein having a purity of >=70wt.% and has a fraction having molecular weight of 5,000-10,000 dalton of <1wt.% of total hydrolyzate, a residual antigen activity of <=10<-5> determined by an ELISA suppressing test using anti-whey protein serum, a ratio of an amount of free amino acid to the amount of total amino acid in the hydrolyzate of 10-15wt.%, a ratio of an amount of free lysine to the amount of total lysine contained in the whey protein of 12-20wt.% and an ammonium content of <=0.2wt.%.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、特異な理化学的性状を
有する乳清蛋白加水分解物及びその製造法に係るもので
あり、腸管吸収性及びアミノ酸バランスに優れ、食餌ア
レルギーに対する予防及び治療効果並びに抗酸化作用を
有し、風味が良好であり、広範な種々の用途に利用でき
る新規な乳清蛋白加水分解物及びその製造法である。本
明細書において、百分率は透過率及び抑制率を除き、特
に断りのない限り、重量による表示である。
FIELD OF THE INVENTION The present invention relates to a whey protein hydrolyzate having unique physicochemical properties and a method for producing the same, which is excellent in intestinal absorbability and amino acid balance and has preventive and therapeutic effects on diet allergy. Further, it is a novel whey protein hydrolyzate which has an antioxidant effect and a good flavor and can be used in a wide variety of applications, and a method for producing the same. In the present specification, percentages are by weight, unless otherwise specified, except for transmittance and suppression.

【0002】[0002]

【従来の技術】最近、消化吸収の観点から、遊離アミノ
酸混合物よりもオリゴペプチドが、吸収速度及び吸収後
のアミノ酸バランスにおいて優れていることが明らかに
されている(酪農科学・食品の研究、第39巻、第A−
283ページ、1990年)。一方、食餌蛋白質に起因
するアレルギー患者が急増し、特に乳児においては乳清
蛋白質、特にβ−ラクトグロブリンに起因するアレルギ
ーが多発していることが明らかになり(酪農科学・食品
の研究、第39巻、第A−283ページ、1990
年)、乳児用食品中の乳清蛋白質の抗原性低減又は乳児
用食品からの乳清蛋白質抗原の実質的除去が、求められ
ている。
2. Description of the Related Art Recently, from the viewpoint of digestion and absorption, it has been revealed that oligopeptides are superior to a mixture of free amino acids in terms of absorption rate and amino acid balance after absorption (dairy science / food research, Volume 39, A-
283, 1990). On the other hand, the number of allergic patients caused by dietary protein has increased rapidly, and it has become clear that allergies caused by whey protein, particularly β-lactoglobulin, are frequently occurring in infants (dairy science and food research, No. 39). Volume, Pages A-283, 1990
), There is a need to reduce the antigenicity of whey protein in infant food or to substantially remove the whey protein antigen from infant food.

【0003】乳児用食品中の乳清蛋白質の抗原性低減又
は乳児用食品からの乳清蛋白質抗原の実質的除去の手段
として、乳清蛋白質の加水分解が広範に採用されている
が、アミノ酸遊離率の極端に低い分解物は苦味を呈する
場合が多く、摂取するときの障害となることがある。ま
た、乳清蛋白質の加水分解物は、熱に対して不安定にな
る場合があるので、溶液の状態では沈殿物の生成、褐変
化等の不都合が生じ、従来の分解物は経口栄養剤等とし
て利用するときに問題があった。
Hydrolysis of whey protein has been widely adopted as a means of reducing the antigenicity of whey protein in baby foods or substantially removing whey protein antigens from baby foods, but amino acid release. Degradation products with extremely low rates often have a bitter taste, which can be an obstacle to ingestion. In addition, since whey protein hydrolyzate may become unstable to heat, inconveniences such as the formation of a precipitate and browning may occur in the state of a solution. There was a problem when using as.

【0004】更に、乳清蛋白加水分解物を食品に使用す
る場合、特に脂肪と共存する食品(例えば、乳幼児用の
調製粉乳では、100g当たり脂肪が27%も含まれて
いる)においては、酸化防止が重大な問題となってい
る。即ち、脂肪を含有する食品においては、栄養学的な
観点から飽和脂肪酸と不飽和脂肪酸とのバランスが考慮
されているが、特に不飽和脂肪酸は容易に酸化される欠
点があり、最近、脳・神経・網膜組織の生体膜に多く含
まれ、その機能発現に関与していると考えられているD
HA等は、一旦酸化されると極めて強い酸化臭を放出
し、製品品質に著しい悪影響を与えるため、酸化の進行
防止が待望されている。
Further, when the whey protein hydrolyzate is used in foods, oxidation is caused especially in foods coexisting with fat (for example, formula powder for infants contains 27% fat per 100 g). Prevention is a serious issue. That is, in foods containing fat, the balance between saturated fatty acids and unsaturated fatty acids has been considered from a nutritional point of view, but especially unsaturated fatty acids have the drawback of being easily oxidized. D is abundant in biological membranes of nerve and retinal tissue and is considered to be involved in the expression of its function.
HA and the like, once oxidized, release an extremely strong oxidative odor and have a significant adverse effect on product quality, and therefore, there is a strong demand for preventing the progress of oxidation.

【0005】一方、摂取したアミノ酸がトランスグルタ
ミナーゼ、グルタノートデヒドロゲナーゼなどによって
分解されて、アンモニアが生成するが、生成したアンモ
ニアは有毒であり、肝臓で直ちに処理される必要があ
り、摂取する食品にアンモニアが含有されていないこと
が必要である。このような点から、乳清蛋白加水分解物
にも、アンモニアが含有されていないことが、極めて重
要である。
On the other hand, the ingested amino acid is decomposed by transglutaminase, glutanote dehydrogenase and the like to produce ammonia, but the produced ammonia is toxic and needs to be immediately processed by the liver, and ammonia should be added to foods to be ingested. Is required to be contained. From this point, it is extremely important that the whey protein hydrolyzate does not contain ammonia.

【0006】また、成長した動物の窒素平衡は、窒素の
最低代謝量に見合う量の窒素を摂取すればよいが、この
窒素を単にアンモニアとして与えても無効であり、必須
アミノ酸として摂取しなければならない。そのために
は、摂取する食品に必要量の必須アミノ酸が含まれてい
なければならない。
[0006] Further, the nitrogen equilibrium of grown animals can be obtained by ingesting an amount of nitrogen commensurate with the minimum metabolism of nitrogen, but it is ineffective to give this nitrogen as ammonia alone, and if it is not ingested as an essential amino acid. I won't. To do this, the food that you eat must contain the required amount of essential amino acids.

【0007】以上のような蛋白質及びアミノ酸の栄養・
生理学の背景から、乳清蛋白質を酵素で加水分解した分
解物を製造する種々の方法が開発されているが、それら
の幾つかを例示すれば次のとおりである。
Nutrition of the above proteins and amino acids
From the physiological background, various methods for producing a hydrolyzate of whey protein with an enzyme have been developed, and some of them are as follows.

【0008】1)乳清蛋白質をバシラス・サチリス由来
のエンドペプチダーゼとトリプシンの2種類の酵素、又
はバシラス・サチリス由来のエンドペプチダーゼ、トリ
プシン及びキモトリプシンの3種類の酵素で分解し、分
子量2,000ダルトン以下、抗原残存率10-4以下、
アミノ酸遊離率が5%以下のオリゴペプチド混合物が開
示されている(特開平4−248959号公報)。
1) Whey protein is decomposed by two kinds of enzymes, endopeptidase and trypsin derived from Bacillus subtilis, or three kinds of enzymes, endopeptidase, trypsin and chymotrypsin derived from Bacillus subtilis, and the molecular weight is 2,000 daltons. The antigen residual rate is 10 -4 or less,
An oligopeptide mixture having an amino acid liberation rate of 5% or less is disclosed (JP-A-4-248959).

【0009】2)乳蛋白質をアルカリプロテアーゼで分
解し、ジペプチド及びトリペプチドが75モル%以上、
アミノ酸遊離率が5%未満、4個以上のアミノ酸からな
り、かつ平均鎖長6.2のペプチドが20モル%未満の
分解物が開示されている(特表平5−505304号公
報)。
2) Degradation of milk protein with alkaline protease to obtain dipeptides and tripeptides of 75 mol% or more,
A degradation product having an amino acid liberation rate of less than 5%, consisting of 4 or more amino acids and having a peptide with an average chain length of 6.2 less than 20 mol% is disclosed (Japanese Patent Publication No. 5-505304).

【0010】3)乳清、カゼイン、大豆をペプシン、ト
リプシン・キモトリプシンで分解し、限外濾過し、4〜
10個のアミノ酸を有するペプチドが40〜60%であ
り、分子量60,000ダルトン以下のオリゴペプチド
が開示されている(特開平3−187348号公報)。
3) Whey, casein and soybeans are decomposed with pepsin, trypsin and chymotrypsin, ultrafiltered, and 4 to
A peptide having 10 amino acids is 40 to 60%, and an oligopeptide having a molecular weight of 60,000 daltons or less is disclosed (JP-A-3-187348).

【0011】4)乳清蛋白質を熱変性させながらpH6
〜10、60〜80℃で分解し、酵素を加熱失活し、分
子量10000ダルトン以下、メインピーク1,000
〜5,000、平均ペプチド鎖長3〜8、遊離アミノ酸
含量20%以下、β−ラクトグロブリンの抗原性1/1
0,000以下の分解物が開示されている(特開平4−
112753号公報)。
4) pH 6 while denaturing the whey protein by heat
Decomposes at -10, 60-80 ° C, deactivates the enzyme by heating, molecular weight 10,000 or less, main peak 1,000
~ 5,000, average peptide chain length 3-8, free amino acid content 20% or less, β-lactoglobulin antigenicity 1/1
Disintegration products of 10,000 or less have been disclosed (JP-A-4-
No. 112753).

【0012】5)牛乳蛋白質をトリプシン、α−キモト
リプシン、アスペルギルス属、バチルス属菌の酵素で分
解し、分子量10,000ダルトン以下の経口寛容誘導
能を有する低アレルゲン性ペプチドが開示されている
(特開平5−5000号公報)。
5) A low allergenic peptide having a molecular weight of 10,000 daltons or less and having an oral tolerance inducing property is disclosed in which milk protein is decomposed by enzymes of trypsin, α-chymotrypsin, Aspergillus and Bacillus. Kaihei 5-5000).

【0013】6)カゼインを酸性プロテアーゼで分解
し、中性でペプチダーゼで分解し、分子量3,000ダ
ルトン以下、遊離アミノ酸含量30〜55%、αS −カ
ゼインに対するインヒビションELISA試験がαS
カゼインの10,000分の1以下、5%溶液の苦味官
能値がカフェイン0.04%水溶液相当以下のペプチド
が開示されている(特開平6−113893号公報)。
6) Casein is decomposed with an acid protease, neutralized with peptidase, and has a molecular weight of 3,000 daltons or less, a free amino acid content of 30 to 55%, and an inhibition ELISA test for α S -casein is α S-.
A peptide in which the bitterness functional value of a 5% solution of 10,000 times or less of casein is equivalent to 0.04% of caffeine aqueous solution or less is disclosed (JP-A-6-113893).

【0014】7)ホエーを中性プロテアーゼ(アスペル
ギルス属)を用いてpH5〜11で加水分解し、pH2
〜4で加熱し、沈殿を除去し、ジペプチド及びトリペプ
チドを50%の割合で得る方法が開示されている(特公
平5−82412号公報)。
7) Whey was hydrolyzed with neutral protease (Aspergillus sp.) At pH 5 to 11 to give pH 2
A method of heating at ~ 4 to remove the precipitate and obtaining a dipeptide and a tripeptide in a ratio of 50% is disclosed (Japanese Patent Publication No. 5-82412).

【0015】[0015]

【発明が解決しようとする課題】しかしながら、前記従
来技術においては、乳清蛋白加水分解物の抗原性の低
下、苦味の改善、遊離アミノ酸含量、分子量分布等につ
いては、考慮されているが、乳清蛋白加水分解物のアン
モニア含有量及び抗酸化作用については何等考慮されて
いない。そのため、従来、乳清蛋白加水分解物を広範な
食品に使用できないという不都合があった。
However, in the above-mentioned conventional techniques, reduction of the antigenicity of whey protein hydrolyzate, improvement of bitterness, free amino acid content, molecular weight distribution, etc. are taken into consideration. No consideration is given to the ammonia content and antioxidant activity of the purified protein hydrolyzate. Therefore, conventionally, there has been a disadvantage that the whey protein hydrolyzate cannot be used for a wide range of foods.

【0016】本発明者らは、前記の従来技術に鑑みて鋭
意研究を行い、乳清蛋白質を加水分解することによって
得られ、食餌アレルギーの回避、予防及び治療に有効で
あり、消化吸収に優れ、アンモニア含有量が低く、かつ
抗酸化作用を有し、広範囲な用途に利用できる風味良好
な乳清蛋白加水分解物及びその製造法を見い出し、本発
明を完成した。
The inventors of the present invention have conducted extensive studies in view of the above-mentioned prior art and obtained by hydrolyzing whey protein, which is effective in avoiding, preventing and treating diet allergy and is excellent in digestion and absorption. The present invention has been completed by finding a whey protein hydrolyzate having a low ammonia content, an antioxidant effect, and a good flavor which can be used in a wide range of applications, and a method for producing the same.

【0017】本発明の目的は、腸管吸収及びアミノ酸バ
ランスに優れ、食餌アレルギーの予防及び治療効果並び
に抗酸化作用を有し、アンモニア含有量が低く、広範囲
な用途に利用できる風味良好な乳清蛋白加水分解物及び
その製造法を提供することである。
The object of the present invention is whey protein which is excellent in intestinal absorption and amino acid balance, has a preventive and therapeutic effect on diet allergy and an antioxidant effect, has a low ammonia content and can be used in a wide range of applications. It is to provide a hydrolyzate and a method for producing the same.

【0018】[0018]

【課題を解決するための手段】前記課題を解決する本発
明の第1の発明は、純度が少なくとも70%(重量)の
乳清蛋白質の加水分解物であって、次のa)〜h)の理
化学的性質; a)分子量5,000〜10,000ダルトンの画分
が、全加水分解物の1%(重量)未満であること、 b)抗乳清蛋白質血清を用いたエライザ抑制試験法によ
り測定した抗原残存活性が10-5以下であること、 c)加水分解物の全アミノ酸の量に対する遊離アミノ酸
の量の割合が10〜15%(重量)であること、 d)乳清蛋白質に含まれる全リジンの量に対する遊離リ
ジンの量の割合が12〜20%(重量)であること、 e)アンモニア含量が0.2%(重量)以下であるこ
と、 f)10%(重量)溶液を1cmのセル、540nmで
測定した透過率が98%以上であること、 g)pH4〜7の5%(重量)溶液を120℃で10分
間加熱して沈殿を生じないこと、及び h)抗酸化作用を有すること、を有することを特徴とす
る風味良好な乳清蛋白加水分解物である。
The first invention of the present invention for solving the above-mentioned problems is a hydrolyzate of whey protein having a purity of at least 70% (by weight), and the following a) to h) are provided. A) The fraction having a molecular weight of 5,000 to 10,000 daltons is less than 1% (by weight) of the total hydrolyzate, b) An ELISA inhibition test method using anti-whey protein serum. The residual antigen activity measured by the method is 10 -5 or less, c) the ratio of the amount of free amino acids to the amount of total amino acids of the hydrolyzate is 10 to 15% (by weight), and d) the whey protein. The ratio of the amount of free lysine to the amount of total lysine contained is 12 to 20% (by weight), e) the ammonia content is 0.2% (by weight) or less, and f) the 10% (by weight) solution. Is a 1 cm cell and the transmittance measured at 540 nm is 8% or more, g) a 5% (by weight) solution having a pH of 4 to 7 is heated at 120 ° C. for 10 minutes to prevent precipitation, and h) has an antioxidant effect. It is a whey protein hydrolyzate with a good flavor.

【0019】前記課題を解決する本発明の第2の発明
は、純度が少なくとも70%(重量)の乳清蛋白質を1
5%(重量)以下の濃度で水に溶解し、該水溶液のpH
を7.5〜10に調整し、該水溶液にバシラス・サチリ
ス(Bacillus subtilis) 由来のエンドペプチダーゼ及び
乳酸菌由来のエキソペプチダーゼの2種類の蛋白分解酵
素を添加して加水分解を開始し、分解液中の遊離リジン
量を経時的に測定し、出発原料である乳清蛋白質に含ま
れる全リジンの量に対する遊離リジンの量の割合が12
〜20%(重量)の範囲で加水分解を停止し、限外濾過
して分子量10,000ダルトン以上の画分を完全に除
去することを特徴とする風味良好な乳清蛋白加水分解物
の製造法である。
A second aspect of the present invention which solves the above-mentioned problems is to provide whey protein having a purity of at least 70% (by weight).
Dissolved in water at a concentration of 5% (weight) or less, the pH of the aqueous solution
Was adjusted to 7.5-10, and two types of proteolytic enzymes, an endopeptidase derived from Bacillus subtilis and an exopeptidase derived from lactic acid bacteria, were added to the aqueous solution to initiate hydrolysis, and The amount of free lysine was measured with time, and the ratio of the amount of free lysine to the amount of total lysine contained in the whey protein as the starting material was 12%.
To 20% (by weight), hydrolysis is stopped, and ultrafiltration is performed to completely remove a fraction having a molecular weight of 10,000 daltons or more, and a whey protein hydrolyzate having a good flavor is produced. Is the law.

【0020】次に本発明について詳述するが、本発明の
理解を容易にするために、本発明の第2の発明から説明
する。本発明の方法の出発原料として使用する乳清蛋白
質は、少なくとも70%の純度を有する市販品等が使用
可能であり、乳清蛋白濃縮物(WPC)、乳清蛋白分離
物(WPI)として知られているより純度の高い市販品
等が好適である。これらの乳清蛋白質を15%以下、望
ましくは8〜12%、の濃度で水に溶解し、アルカリ水
溶液でpHを7.5〜10、望ましくは8〜9、に調整
する。
Next, the present invention will be described in detail, but in order to facilitate understanding of the present invention, description will be given from the second invention of the present invention. The whey protein used as a starting material in the method of the present invention may be a commercially available product having a purity of at least 70%, and is known as a whey protein concentrate (WPC) or a whey protein isolate (WPI). Commercially available products having higher purity than the existing products are suitable. These whey proteins are dissolved in water at a concentration of 15% or less, preferably 8 to 12%, and the pH is adjusted to 7.5 to 10, preferably 8 to 9 with an alkaline aqueous solution.

【0021】次いで、前記乳清蛋白溶液にバシラス・サ
チリス(Bacillus subtilis) 由来のエンドペプチダーゼ
及び乳酸菌由来のエキソペプチダーゼの2種類の蛋白分
解酵素を添加する。その他、トリプシン、パパイン等の
エンドペプチダーゼを極少量添加することもできる。た
だし、乳酸菌由来以外のエキソペプチダーゼ(パンクレ
アチン等を含む)の添加は、風味を悪化させるので避け
るべきである。バシラス・サチリス(Bacillus subtili
s) 由来のエンドペプチダーゼは、市販品等が使用可能
であり、乳清蛋白質1g当たり1,000〜7,500
PUN単位(この単位については後記する)、望ましく
は2,000〜3,000PUN単位、の割合で添加す
る。
Next, two kinds of proteolytic enzymes, an endopeptidase derived from Bacillus subtilis and an exopeptidase derived from lactic acid bacteria, are added to the whey protein solution. In addition, a very small amount of endopeptidase such as trypsin and papain can be added. However, the addition of exopeptidases (including pancreatin etc.) other than those derived from lactic acid bacteria deteriorates the flavor and should be avoided. Bacillus subtili
As the endopeptidase derived from s), commercially available products can be used, and 1,000 to 7,500 per 1 g of whey protein can be used.
PUN units (this unit will be described later), preferably 2,000 to 3,000 PUN units, are added.

【0022】PUN単位は、カゼイン[ハマーシュタイ
ン(Hammerstein) 。メルク社製]にバシラス・サチリス
(Bacillus subtilis) 由来のエンドペプチダーゼを作用
させ、30℃で1分間に1μgのチロシンに相当するア
リルアミノ酸のフォリン試薬での呈色反応を示す酵素活
性を1PUN単位とする。
The PUN unit is casein [Hammerstein]. Made by Merck] to Bacillus subtilis
The enzyme activity showing the color reaction of allyl amino acid corresponding to 1 μg of tyrosine with the Folin reagent at 30 ° C. for 1 minute is set to 1 PUN unit by allowing the endopeptidase derived from (Bacillus subtilis) to act.

【0023】乳酸菌由来のエキソペプチダーゼは、例え
ば特公昭54−36235号公報第6欄4行「(3)使
用する酵素について」の項に記載の方法により次のとお
り製造することができる。乳酸菌(ビフィズス菌を含
む)を公知の方法(例えば特公昭48−43878号公
報記載の方法)により培養し、得られた培養液を遠心分
離して乳酸菌菌体を回収し、滅菌水に菌体を懸濁し、遠
心分離して乳酸菌菌体を回収する操作を2回反復し、菌
体を洗浄し、20%の濃度で菌体を滅菌水に懸濁し、菌
体破砕機[例えば、ダイノミル(Willy Bachnfen Engin
eering Works)社製。KDL型]により菌体を破砕し、
凍結乾燥し、乳酸菌由来のエキソペプチダーゼ粉末を得
る。この酵素を乳清蛋白質1g当たり20〜200活性
単位(この単位については後記する)、望ましくは60
〜90活性単位、の割合で添加する。
The exopeptidase derived from lactic acid bacteria can be produced, for example, by the method described in the section of “(3) Enzyme used” in JP-B No. 54-36235, column 6, line 4). Lactic acid bacteria (including bifidobacteria) are cultivated by a known method (for example, the method described in Japanese Patent Publication No. 48-43878), the obtained culture solution is centrifuged to collect the lactic acid bacterium cells, and the cells are sterilized in sterile water. The procedure of suspending the cells and recovering the lactic acid bacteria cells by centrifugation is repeated twice, the cells are washed, and the cells are suspended in sterilized water at a concentration of 20%, and the cell crusher [for example, Dynomill ( Willy Bachnfen Engin
eering Works) product. KDL type] to crush the cells,
Lyophilization is performed to obtain lactic acid bacterium-derived exopeptidase powder. 20 to 200 activity units of this enzyme per 1 g of whey protein (this unit will be described later), preferably 60
~ 90 activity units.

【0024】活性単位は、次の方法により測定する。エ
キソペプチダーゼを含有する粉末を0.2g/100m
lの割合で0.1モルのリン酸緩衝液(pH7.0)に
分散又は溶解して酵素溶液を調製する。一方、ロイシル
パラニトロアニリド(国産化学社製。以後Leu−pN
Aと記載する)を0.1モルのリン酸緩衝液(pH7.
0)に溶解して2mMの基質溶液を調製する。酵素溶液
1mlに基質溶液1mlを添加し、37℃で5分間反応
させ、のち30%の酢酸溶液2mlを添加して反応を停
止させる。反応液をメンブランフィルターで濾過し、波
長410nmで濾液の吸光度を測定する。エキソペプチ
ダーゼの活性単位は、1分間に1μmolのLeu−p
NAを分解するのに必要な酵素量を1活性単位と定義
し、次式により求めた。 活性単位(粉末1g当たり)=20×(A/B) ただし、前記の式においてA及びBは、それぞれ波長4
10nmにおける試料の吸光度及び0.25mMパラニ
トロアニリンの吸光度を示す。
The activity unit is measured by the following method. 0.2g / 100m of powder containing exopeptidase
An enzyme solution is prepared by dispersing or dissolving in 0.1 mol phosphate buffer (pH 7.0) at a ratio of 1 l. On the other hand, leucylparanitroanilide (manufactured by Kokusan Kagaku Co., Ltd. hereafter, Leu-pN
Described as A) in 0.1 molar phosphate buffer (pH 7.
0) to prepare a 2 mM substrate solution. 1 ml of the substrate solution is added to 1 ml of the enzyme solution, and the mixture is reacted at 37 ° C. for 5 minutes, and then 2 ml of a 30% acetic acid solution is added to stop the reaction. The reaction solution is filtered with a membrane filter, and the absorbance of the filtrate is measured at a wavelength of 410 nm. The activity unit of exopeptidase is 1 μmol of Leu-p per minute.
The amount of enzyme required for decomposing NA was defined as 1 activity unit, and calculated by the following formula. Active unit (per 1 g of powder) = 20 × (A / B) However, in the above formula, A and B are respectively wavelengths of 4
The absorbance of the sample at 10 nm and the absorbance of 0.25 mM paranitroaniline are shown.

【0025】酵素を添加した溶液を30〜60℃、望ま
しくは45〜55℃に保持して乳清蛋白質の加水分解を
開始する。なお、加水分解反応が進行してpHが低下す
る場合には、そのpHを6以上、好ましくは6〜7に保
持することが望ましい。加水分解を開始後、経時的に分
解液中の遊離リジン量を測定し得る装置、例えば、バイ
オテックアナライザー(旭化成工業社製)等、を用いて
経時的に分解液中の遊離リジン量を測定し、出発原料で
ある乳清蛋白質に含まれる全リジンの量に対する遊離リ
ジンの量の割合が12〜20%、望ましくは14〜17
%、の範囲に達したとき、直ちに反応液を加熱(例え
ば、85℃で15分間等)して酵素を失活させ、加水分
解を停止する。
The enzyme-added solution is kept at 30 to 60 ° C., preferably 45 to 55 ° C. to start the hydrolysis of whey protein. When the hydrolysis reaction proceeds and the pH decreases, it is desirable to maintain the pH at 6 or higher, preferably 6 to 7. After starting hydrolysis, measure the amount of free lysine in the decomposed solution over time using a device that can measure the amount of free lysine in the decomposed solution over time, for example, Biotech Analyzer (Asahi Kasei Co., Ltd.) However, the ratio of the amount of free lysine to the amount of total lysine contained in the whey protein as a starting material is 12 to 20%, preferably 14 to 17
%, The reaction solution is immediately heated (for example, at 85 ° C. for 15 minutes) to inactivate the enzyme and stop the hydrolysis.

【0026】得られた反応液をクエン酸等の酸によりp
Hを5.5〜7の範囲に調整し、公知の装置[例えば、
限外濾過モジュール(旭化成工業社製)等]により限外
濾過し、分子量10,000ダルトン以上の画分を完全
に除去し、目的とする風味良好な乳清蛋白加水分解物を
得る。この乳清蛋白加水分解物を含有する液を、公知の
方法により濃縮し、濃縮液とすることもでき、更にこの
濃縮液を公知の方法により乾燥し、粉末とすることもで
きる。
The obtained reaction solution was treated with an acid such as citric acid to obtain p
H is adjusted to a range of 5.5 to 7 and a known device [for example,
Ultrafiltration module (manufactured by Asahi Kasei Kogyo Co., Ltd.)] to completely remove a fraction having a molecular weight of 10,000 daltons or more to obtain a desired whey protein hydrolyzate having a good taste. The liquid containing the whey protein hydrolyzate can be concentrated by a known method to give a concentrated solution, and the concentrated solution can be dried by a known method to give a powder.

【0027】以上のようにして得られた乳清蛋白加水分
解物は、後記する実施例からも明らかなように次の理化
学的性状を有している。 a)図1に示すとおり、分子量5,000〜10,00
0ダルトンの画分が、全加水分解物の1%(重量)未満
であり、分子量10,000ダルトン以上の画分を含ま
ず、分子量1,000ダルトン未満の画分が70%以上
であり、分子量500ダルトン及び分子量1,000ダ
ルトンにピークを有し、数平均分子量300〜400ダ
ルトン、重量平均分子量600〜800ダルトンであ
る。図1は、実施例1により得られた本発明の乳清蛋白
加水分解物の分子量分布を示し、縦軸及び横軸は、それ
ぞれ分布割合及び分子量を示す。
The whey protein hydrolyzate obtained as described above has the following physicochemical properties as will be apparent from the examples described below. a) As shown in FIG. 1, the molecular weight is 5,000 to 10,000.
The fraction of 0 dalton is less than 1% (by weight) of the total hydrolyzate, does not include the fraction of molecular weight of 10,000 daltons or more, and the fraction of molecular weight of less than 1,000 daltons is 70% or more, It has peaks at a molecular weight of 500 daltons and a molecular weight of 1,000 daltons, and has a number average molecular weight of 300 to 400 daltons and a weight average molecular weight of 600 to 800 daltons. 1 shows the molecular weight distribution of the whey protein hydrolyzate of the present invention obtained in Example 1, and the vertical axis and the horizontal axis show the distribution ratio and the molecular weight, respectively.

【0028】b)図2に示すとおり、抗乳清蛋白質血清
を用いたエライザ抑制試験法により測定した抗原残存活
性が10-5以下、望ましくは10-6以下である。図2
は、実施例1により得られた本発明の乳清蛋白加水分解
物の抗原残存活性を示し、縦軸及び横軸は、それぞれ抑
制割合及び最終試料濃度を示す。図中+及び□は、それ
ぞれ乳清蛋白質及び本発明の乳清蛋白分解物を示す。
B) As shown in FIG. 2, the residual antigen activity measured by the ELISA inhibition test method using anti-whey protein serum is 10 -5 or less, preferably 10 -6 or less. Figure 2
Shows the antigen residual activity of the whey protein hydrolyzate of the present invention obtained in Example 1, and the vertical axis and the horizontal axis show the inhibition ratio and the final sample concentration, respectively. In the figure, + and □ indicate whey protein and the whey protein degradation product of the present invention, respectively.

【0029】c)加水分解物の全アミノ酸の量に対する
遊離アミノ酸の量の割合が10〜15%(重量)、望ま
しくは11〜13%(重量)である。 d)乳清蛋白質に含まれる全リジンの量に対する遊離リ
ジンの量の割合が12〜20%(重量)、望ましくは1
4〜17%(重量)である。 e)アンモニア含量が0.2%(重量)以下、望ましく
は0.1%(重量)以下である。 f)10%溶液を1cmのセル、540nmで測定した
透過率が98%以上である。 g)pH4〜7の5%(重量)溶液を120℃で10分
間加熱して沈殿を生じない。
C) The ratio of the amount of free amino acid to the amount of total amino acid of the hydrolyzate is 10 to 15% (by weight), preferably 11 to 13% (by weight). d) The ratio of the amount of free lysine to the amount of total lysine contained in the whey protein is 12 to 20% (by weight), preferably 1
It is 4 to 17% (weight). e) Ammonia content is 0.2% (weight) or less, preferably 0.1% (weight) or less. f) The transmittance of a 10% solution measured in a 1 cm cell at 540 nm is 98% or more. g) Heating a 5% (by weight) solution of pH 4-7 at 120 ° C. for 10 minutes without precipitation.

【0030】h)図3に示すとおり、公知の抗酸化剤で
あるα−トコフェロールと同等又はそれ以上の抗酸化活
性を有する。図3は、実施例1により得られた本発明の
乳清蛋白加水分解物の抗酸化活性を示し、縦軸及び横軸
は、それぞれ抗酸化能残存率及び時間を示す。図中◇、
+及び□は、それぞれ本発明の乳清蛋白分解物、α−ト
コフェロール及び対照(試料又は標品無添加)を示す。
H) As shown in FIG. 3, it has an antioxidant activity equal to or higher than that of the known antioxidant α-tocopherol. FIG. 3 shows the antioxidant activity of the whey protein hydrolyzate of the present invention obtained in Example 1, and the vertical axis and the horizontal axis respectively show the antioxidant capacity residual rate and time. ◇ 、
+ And □ indicate the whey protein hydrolyzate of the present invention, α-tocopherol, and a control (no sample or standard preparation added), respectively.

【0031】次に、試験例を示して本発明を詳述する。
本発明の試験例においては、次の試験方法を採用した。 (1)分子量の測定方法 高速液体クロマトグラフィー(宇井信生ら編、「タンパ
ク質・ペプチドの高速液体クロマトグラフィー」、化学
増刊第102号、第241ページ、化学同人、1984
年)により次のようにして測定した。ポリハイドロキシ
エチル・アスパルアミド・カラム[ポリエルシー(PolyL
C)社製。直径4.6mm及び長さ200mm]を用い、
20mM塩化ナトリウム、50mMぎ酸により溶出速度
0.4ml/分で溶出した。検出はUV検出器を用い、
データ解析はGPC分析システム(島津製作所製)を使
用した。
Next, the present invention will be described in detail by showing test examples.
In the test example of the present invention, the following test method was adopted. (1) Method for measuring molecular weight High-performance liquid chromatography (edited by Nobuo Ui et al., “High-performance liquid chromatography for proteins and peptides”, Kagaku Special Issue No. 102, page 241, Kagaku Dojin, 1984.
Year) was measured as follows. Polyhydroxyethyl aspartamide column [Poly L (PolyL
Made by C). Diameter 4.6 mm and length 200 mm],
Elution was performed with 20 mM sodium chloride and 50 mM formic acid at an elution rate of 0.4 ml / min. UV detector is used for detection,
The data analysis used the GPC analysis system (made by Shimadzu Corporation).

【0032】(2)抗原残存活性の測定方法 エライザ測定試験法(日本小児アレルギー学会誌、第1
巻、第36ページ、1978年)により次のようにして
測定した。96穴プレート(ヌンク社製)に乳清蛋白質
をコーティングし、洗浄し、ウサギ抗乳清蛋白質血清及
び加水分解物試料の混合液をプレートの穴に供給して反
応させ、洗浄後アルカリホスファターゼ標識ヤギ抗ウサ
ギIgG抗体(ザイメッド・ラボラトリー社製)を反応
させ、洗浄後p−ニトロフェニル・リン酸ナトリウムを
添加し、30分後に5N水酸化ナトリウムを添加して反
応を停止させ、反応生成物をマイクロプレートリーダー
(和光純薬工業社製)で測定した。なお、抑制用被検抗
原液添加による反応抑制の程度の表現には次の式で算出
した抑制率を用いた。 抑制率(%)=(1−被検抗原液での吸光度/対照の吸
光度)×100 ただし、被検抗原液の吸光度及び対照の吸光度は抗乳清
蛋白血清にそれぞれ等量の被検試料液又は希釈液の混合
液を入れた穴の反応後測定した値である。
(2) Method of measuring residual activity of antigens ELISA test method (Journal of Japanese Society of Pediatric Allergy, No. 1
Vol., P. 36, 1978). 96-well plate (manufactured by Nunc) is coated with whey protein and washed, and a mixture of rabbit anti-whey protein serum and hydrolyzate sample is supplied to the well of the plate to react, and after washing, alkaline phosphatase-labeled goat Anti-rabbit IgG antibody (manufactured by Zymed Laboratories) was reacted, and after washing, p-nitrophenyl sodium phosphate was added, and after 30 minutes, 5N sodium hydroxide was added to stop the reaction, and the reaction product was micronized. It measured with the plate reader (made by Wako Pure Chemical Industries Ltd.). In addition, the suppression rate calculated by the following formula was used to express the degree of reaction suppression by the addition of the test antigen solution for suppression. Inhibition rate (%) = (1-absorbance of test antigen solution / absorbance of control) x 100 However, the absorbance of the test antigen solution and the absorbance of the control are the same as the test sample solution of anti-whey protein serum. Alternatively, it is a value measured after the reaction of the hole in which the mixed liquid of the diluting liquid is put.

【0033】(3)アミノ酸組成の測定方法 トリプトファン、システイン及びメチオニン以外のアミ
ノ酸については、試料を6N塩酸で110℃、24時間
加水分解し、トリプトファンについては、水酸化バリウ
ムで110℃、22時間アルカリ分解し、システイン及
びメチオニンについては、過ぎ酸処理後6N塩酸で11
0℃、18時間加水分解し、それぞれアミノ酸分析機
(日立製作所製。835型)により分解し、アミノ酸の
質量を測定した。
(3) Method for measuring amino acid composition For amino acids other than tryptophan, cysteine and methionine, samples were hydrolyzed with 6N hydrochloric acid at 110 ° C. for 24 hours, and for tryptophan, barium hydroxide at 110 ° C. for 22 hours. After decomposition, cysteine and methionine were treated with 6N hydrochloric acid after the treatment with excess acid.
It was hydrolyzed at 0 ° C. for 18 hours and decomposed with an amino acid analyzer (manufactured by Hitachi Ltd., model 835) to measure the mass of the amino acid.

【0034】(4)遊離アミノ酸組成の測定方法 スルホサリチル酸で試料を除蛋白し、アミノ酸分析機
(日立製作所製。835型)により分析し、前記アミノ
酸組成の分析で得られた各アミノ酸の質量に対する遊離
アミノ酸質量の百分率を算出した。
(4) Method for measuring free amino acid composition The sample was deproteinized with sulfosalicylic acid and analyzed by an amino acid analyzer (Hitachi, Ltd. model 835), based on the mass of each amino acid obtained by the above amino acid composition analysis. The percentage of free amino acid mass was calculated.

【0035】(5)遊離リジン含量の測定方法 リジン測定用酵素電極、20mML−リジン標準液、
0.1M燐酸L−リジン測定用緩衝液及び洗浄用界面活
性剤(いずれも旭化成工業社製)を用い、バイオテック
アナライザー(旭化成工業社製)により遊離リジン濃度
をバッチ式又はオンラインで測定し、乳清蛋白質のリジ
ン含有量に対する分解溶液のリジン含有量から全リジン
に対する遊離リジンの量の割合を算出した。
(5) Method for measuring free lysine content Enzyme electrode for lysine measurement, 20 mM L-lysine standard solution,
Using a 0.1 M L-lysine phosphate measurement buffer and a washing surfactant (both manufactured by Asahi Kasei Kogyo Co., Ltd.), the free lysine concentration was measured in a batch or online with a Biotech analyzer (Asahi Kasei Kogyo Co., Ltd.), The ratio of the amount of free lysine to the total lysine was calculated from the lysine content of the decomposition solution to the lysine content of whey protein.

【0036】(6)アンモニア含量の測定方法 スルホサリチル酸で試料を除蛋白し、アミノ酸分析機
(日立製作所製。835型)により分析し、アンモニア
の質量を測定した。
(6) Method for measuring ammonia content The sample was deproteinized with sulfosalicylic acid and analyzed with an amino acid analyzer (Hitachi Ltd. model 835) to measure the mass of ammonia.

【0037】(7)抗酸化作用の測定方法 リノール酸、β−カロチンをTween20で乳化し、
これに試料又は標品としてα−トコフェロールを添加
し、経時変化を比色法により測定した[フィトケミスト
リー(Phytochemistry)、第10巻、第1445ページ、
1971年]。リノール酸、β−カロチン、Tween
20、試料及びα−トコフェロールの最終濃度は、それ
ぞれ0.96mg/ml、4.8μg/ml、9.6m
g/ml、0.19mg/ml及び0.19mg/ml
であった。
(7) Method for measuring antioxidant activity Linoleic acid and β-carotene were emulsified with Tween 20,
Α-Tocopherol was added to this as a sample or a standard, and its change with time was measured by a colorimetric method [Phytochemistry, vol. 10, p. 1445,
1971]. Linoleic acid, β-carotene, Tween
The final concentrations of 20, sample and α-tocopherol were 0.96 mg / ml, 4.8 μg / ml and 9.6 m, respectively.
g / ml, 0.19 mg / ml and 0.19 mg / ml
Met.

【0038】試験例1 この試験は、抗原性と密接に関連する高分子量画分の比
率を指標として、加水分解に供する乳清蛋白質溶液の好
適な濃度を調べるために行った。 1)試料の調製 表1に示すとおり乳清蛋白質濃度を変更したことを除
き、実施例1と同一の方法により乳清蛋白質溶液を加水
分解し、7種類の試料を調製した。
Test Example 1 This test was carried out to examine a suitable concentration of the whey protein solution to be subjected to hydrolysis, using the ratio of the high molecular weight fraction closely related to the antigenicity as an index. 1) Preparation of sample The whey protein solution was hydrolyzed in the same manner as in Example 1 except that the whey protein concentration was changed as shown in Table 1 to prepare 7 types of samples.

【0039】2)試験方法 分子量5,000〜10,000ダルトンの画分の比率
は前記分子量の測定方法により求めた。
2) Test method The ratio of the fraction having a molecular weight of 5,000 to 10,000 daltons was determined by the above-mentioned molecular weight measuring method.

【0040】3)試験結果 この試験結果は、表1に示すとおりである。表1から明
らかなように、分子量5,000〜10,000ダルト
ンの画分が1%未満となる乳清蛋白質の濃度は、15%
以下、望ましくは12%以下であることが判明した。反
応効率を考慮するならば、8〜12%が最も望ましい。
尚、乳清蛋白質の種類、バシラス・サチリス由来のエン
ドペプチダ−ゼ及び乳酸菌由来のエキソペプチダ−ゼの
種類、及び後記する試験例3において求められた範囲内
で、その酵素量を変更して試験したが、ほぼ同様の結果
が得られた。
3) Test Results The test results are shown in Table 1. As is clear from Table 1, the concentration of whey protein in which the fraction having a molecular weight of 5,000 to 10,000 daltons is less than 1% is 15%.
Below, it was found that it is desirably 12% or less. Considering the reaction efficiency, 8-12% is most desirable.
It should be noted that the whey protein was tested by varying the enzyme amount within the range of the type of whey protein, the type of endopeptidase derived from Bacillus subtilis and the type of exopeptidase derived from lactic acid bacteria, and the range determined in Test Example 3 described below. , And almost the same result was obtained.

【0041】[0041]

【表1】 [Table 1]

【0042】試験例2 この試験は、抗原性を指標として、加水分解のために好
適な酵素処理初発pH範囲を調べるために行った。 1)試料の調製 加水分解の初発pHを次のとおり変更したことを除き、
実施例1と同一の方法により乳清蛋白質溶液を加水分解
し、5種類の試料を調製した。 試料1:初発pHをpH6.5に調整した後、加水分解
を行った。 試料2:初発pHをpH7.5に調整した後、加水分解
を行った。 試料3:初発pHをpH8.0に調整した後、加水分解
を行った。 試料4:初発pHをpH9.0に調整した後、加水分解
を行った。 試料5:初発pHをpH10.0に調整した後、加水分
解を行った。
Test Example 2 This test was carried out to examine the initial pH range of enzyme treatment suitable for hydrolysis using the antigenicity as an index. 1) Preparation of sample, except that the initial pH of hydrolysis was changed as follows:
The whey protein solution was hydrolyzed in the same manner as in Example 1 to prepare 5 types of samples. Sample 1: After initial pH was adjusted to pH 6.5, hydrolysis was performed. Sample 2: After initial pH was adjusted to pH 7.5, hydrolysis was performed. Sample 3: After initial pH was adjusted to pH 8.0, hydrolysis was performed. Sample 4: After initial pH was adjusted to pH 9.0, hydrolysis was performed. Sample 5: After the initial pH was adjusted to pH 10.0, hydrolysis was performed.

【0043】2)試験方法 抗原残存活性は、前記抗原残存活性の測定方法により測
定した。
2) Test method The residual antigen activity was measured by the method for measuring residual antigen activity.

【0044】3)試験結果 この試験結果は、表2に示すとおりである。表2から明
らかなように、低い抗原性の乳清蛋白加水分解物を得る
ためには、加水分解のための初発pHは7.5〜10.
0、望ましくは8〜9であることが判明した。尚、乳清
蛋白質の種類、バシラス・サチリス由来のエンドペプチ
ダ−ゼ及び乳酸菌由来のエキソペプチダ−ゼの種類、及
び後記する試験例3において求められた範囲内で、その
酵素量を変更して試験したが、ほぼ同様の結果が得られ
た。
3) Test Results The test results are shown in Table 2. As is clear from Table 2, in order to obtain a whey protein hydrolyzate having a low antigenicity, the initial pH for hydrolysis is 7.5 to 10.
It was found to be 0, preferably 8-9. It should be noted that the whey protein was tested by varying the enzyme amount within the range of the type of whey protein, the type of endopeptidase derived from Bacillus subtilis and the type of exopeptidase derived from lactic acid bacteria, and the range determined in Test Example 3 described below. , And almost the same result was obtained.

【0045】[0045]

【表2】 [Table 2]

【0046】試験例3 この試験は、抗原性と密接に関連する高分子量画分の比
率、アンモニア含量、及び抗酸化活性を指標として、酵
素の適正な使用量を調べるために行った。 1)試料の調製 表3に示すように酵素の使用量を変更したことを除き、
実施例1と同一の方法により乳清蛋白質溶液を加水分解
し、12種類の試料を調製した。なお、試料番号1及び
7は、30時間加水分解を行っても遊離リジン量が、1
4%に到達しなかったので、その時点で加水分解を終了
した。
Test Example 3 This test was carried out in order to examine the proper amount of the enzyme to be used, with the ratio of the high molecular weight fraction closely related to the antigenicity, the ammonia content and the antioxidant activity as indicators. 1) Preparation of sample, except that the amount of enzyme used was changed as shown in Table 3.
The whey protein solution was hydrolyzed in the same manner as in Example 1 to prepare 12 types of samples. Samples 1 and 7 had a free lysine content of 1 even after hydrolysis for 30 hours.
Since it did not reach 4%, the hydrolysis was terminated at that point.

【0047】2)試験方法 分子量5,000〜10,000ダルトンの画分の比率
は前記分子量の測定方法、アンモニア含量は前記アンモ
ニア含量の測定方法、及び抗酸化活性は前記抗酸化作用
の測定方法により求めた。なお、試料の抗酸化活性は、
α−トコフェロ−ルの抗酸化活性に対する相対的な強さ
を指標として表わした。
2) Test method The ratio of the fraction having a molecular weight of 5,000 to 10,000 daltons is the method for measuring the molecular weight, the ammonia content is the method for measuring the ammonia content, and the antioxidant activity is the method for measuring the antioxidant action. Sought by. The antioxidant activity of the sample is
The relative strength of α-tocopherol against the antioxidant activity was expressed as an index.

【0048】3)試験結果 この試験結果は、表3に示すとおりである。表3から明
らかなように、分子量5,000〜10,000ダルト
ンの画分が1%以下、アンモニア含量が0.2%以下、
かつα−トコフェロ−ルと同等又はそれ以上の抗酸化活
性となる酵素の使用量は、乳清蛋白質1gあたりバシラ
ス・サチリス由来のエンドペプチダーゼが1,000〜
7,500PUN単位、望ましくは2,000〜3,0
00PUN単位、乳酸菌由来のエキソペプチダーゼが2
0〜200活性単位、望ましくは60〜90活性単位の
範囲であることが判明した。尚、乳清蛋白質の種類、及
びバシラス・サチリス由来のエンドペプチダ−ゼ及び乳
酸菌由来のエキソペプチダ−ゼの種類を変更して試験し
たが、ほぼ同様の結果が得られた。
3) Test Results The test results are shown in Table 3. As is clear from Table 3, the fraction having a molecular weight of 5,000 to 10,000 daltons is 1% or less, the ammonia content is 0.2% or less,
In addition, the amount of the enzyme having an antioxidant activity equivalent to or higher than that of α-tocopherol is from 1,000 to 1,000 of the endopeptidase derived from Bacillus subtilis per 1 g of whey protein.
7,500 PUN units, preferably 2,000-3,0
00 PUN units, 2 exopeptidases derived from lactic acid bacteria
It has been found to range from 0 to 200 activity units, preferably 60 to 90 activity units. In addition, the type of whey protein and the types of endopeptidase derived from Bacillus subtilis and exopeptidase derived from lactic acid bacteria were changed and tested, but almost the same results were obtained.

【0049】[0049]

【表3】 [Table 3]

【0050】試験例4 この試験は、風味、抗原性と密接に関連する高分子量画
分の比率、及び風味に影響を及ぼす遊離アミノ酸の含量
を指標として、加水分解物の適正なリジンの遊離率を調
べるために行った。 1)試料の調製 表4に示すとおり、加水分解反応を、所望の遊離リジン
の量の割合で、適宜、酵素を失活させて停止させたこと
を除き、実施例1と同一の方法により7種類の試料を調
製した。
Test Example 4 In this test, the appropriate lysine release rate of the hydrolyzate was determined by using the ratio of the high molecular weight fraction closely related to flavor and antigenicity, and the content of free amino acids that affect flavor. Went to find out. 1) Preparation of sample As shown in Table 4, the hydrolysis reaction was carried out in the same manner as in Example 1 except that the enzyme was appropriately inactivated and stopped at a ratio of the desired amount of free lysine. Different types of samples were prepared.

【0051】2)試験方法 分子量5,000〜10,000ダルトンの画分の比率
及び遊離アミノ酸の含量は、いずれも前記の方法により
求めた。なお、風味は下記の方法により試験した。 a)風味試験 男女各10名のパネルにより官能的に試験し、風味良
(0点)から風味不良(3点)までの4段階に評価し、
評価点の平均値から、0.5点未満を良、0.5点以上
〜1.5点未満をやや良、1.5点以上〜2.5点未満
をやや不良及び2.5点以上〜3.0点未満を不良と判
定した。
2) Test method The ratio of the fraction having a molecular weight of 5,000 to 10,000 daltons and the content of free amino acids were determined by the above-mentioned method. The flavor was tested by the following method. a) Flavor test A sensory test was conducted by a panel of 10 people each for men and women, and it was evaluated in four grades from good flavor (0 point) to poor flavor (3 points).
From the average value of the evaluation points, less than 0.5 points is good, 0.5 points or more and less than 1.5 points is a little good, 1.5 points or more and less than 2.5 points is a little bad and 2.5 points or more It was judged to be defective when less than 3.0 points.

【0052】3)試験結果 この試験の結果は、表4に示すとおりである。表4から
明らかなように風味が良い乳清蛋白質分解物は、リジン
の遊離率が12〜20%、望ましくは14〜17%であ
ることが判明した。尚、乳清蛋白質の種類、バシラス・
サチリス由来のエンドペプチダ−ゼ及び乳酸菌由来のエ
キソペプチダ−ゼの種類、及び前記する試験例3におい
て求められた範囲内で、その酵素量を変更して試験した
が、ほぼ同様の結果が得られた。
3) Test Results The results of this test are shown in Table 4. As is clear from Table 4, the whey protein hydrolyzate having a good flavor was found to have a lysine release rate of 12 to 20%, preferably 14 to 17%. The type of whey protein, Bacillus
The type of endopeptidase derived from S. subtilis and the exopeptidase derived from lactic acid bacteria, and the enzyme amount were varied within the range determined in Test Example 3 described above, and the same results were obtained.

【0053】[0053]

【表4】 [Table 4]

【0054】試験例5 この試験は、抗原性と密接に関連する高分子量画分の比
率、抗原性、食品素材として好適な性質である透明性の
基準となる透過率及び熱安定性を指標として、加水分解
物の好適な瀘過方法を調べるために行った。 1)試料の調製 表5に示すとおり瀘過膜(分画分子量)を変更したこと
を除き、実施例1と同一の方法により乳清蛋白質溶液を
加水分解し、3種類の試料を調製した。なお、瀘過膜と
して、旭化成工業社製の分画分子量3,000ダルトン
及び10,000ダルトンの限外瀘過膜、及び孔径0.
25μm の精密瀘過膜を使用した。
Test Example 5 In this test, the ratio of the high molecular weight fraction closely related to the antigenicity, the antigenicity, and the transmittance and heat stability, which are the criteria of transparency which is a property suitable as a food material, are used as indexes. , To determine a suitable filtration method for the hydrolyzate. 1) Preparation of sample As shown in Table 5, the whey protein solution was hydrolyzed in the same manner as in Example 1 except that the filtration membrane (molecular weight cut-off) was changed to prepare three types of samples. As the filtration membrane, an ultrafiltration membrane having a cut-off molecular weight of 3,000 daltons and 10,000 daltons manufactured by Asahi Kasei Kogyo Co., Ltd., and a pore size of 0.
A 25 μm precision filtration membrane was used.

【0055】2)試験方法 分子量5,000〜10,000ダルトンの画分の比
率、抗原残存活性、透過率、及び熱安定性は、いずれも
前記の方法により求めた。
2) Test method The ratio of the fraction having a molecular weight of 5,000 to 10,000 daltons, the residual antigen activity, the transmittance and the thermal stability were all determined by the above-mentioned methods.

【0056】3)試験結果 この試験の結果は、表5に示すとおりである。表5から
明らかなように、分子量5,000〜10,000ダル
トンの画分が1%未満、透過率が98%以上、耐熱性を
有する限外濾過処理方法は、クエン酸でpHを5.5〜
7に調整し、分画分子量10,000以下、望ましくは
3,000以下、の限外濾過膜を用いることが必要であ
ることが判明した。尚、乳清蛋白質の種類、バシラス・
サチリス由来のエンドペプチダ−ゼ及び乳酸菌由来のエ
キソペプチダ−ゼの種類、及び前記する試験例3におい
て求められた範囲内で、その酵素量を変更して試験した
が、ほぼ同様の結果が得られた。
3) Test Results The results of this test are shown in Table 5. As is clear from Table 5, the ultrafiltration treatment method having a fraction with a molecular weight of 5,000 to 10,000 daltons of less than 1%, a transmittance of 98% or more, and heat resistance is citric acid at a pH of 5. 5-
It was found that it is necessary to adjust the number to 7 and use an ultrafiltration membrane having a molecular weight cutoff of 10,000 or less, preferably 3,000 or less. The type of whey protein, Bacillus
The type of endopeptidase derived from S. subtilis and the exopeptidase derived from lactic acid bacteria, and the enzyme amount were varied within the range determined in Test Example 3 described above, and the same results were obtained.

【0057】[0057]

【表5】 [Table 5]

【0058】試験例6 この試験は、風味と抗酸化活性を指標として、加水分解
のために好適な酵素の種類を調べるために行った。 1)試料の調製 表6に示すとおり使用する酵素の種類及び添加量を変更
したことを除き、実施例1と同一の方法により6種類の
試料を調製した。なお、酵素としては、バシラス・サチ
リス由来のエンドペプチダーゼとして、ビオプラ−ゼ
6.0S(長瀬生化学工業社製)、乳酸菌由来のエキソ
ペプチダ−ゼとして、後記する参考例1と同様の方法で
調整したラクトバチルス・ヘルベティカス菌体破砕物又
はビフィドバクテリウム・プレビス菌体破砕物、その他
のエンドペプチダーゼとして、トリプシン(ノボノルデ
ィスク社製)、及びその他のエキソペプチダ−ゼとし
て、デナチ−ムAP(長瀬産業社製)を用いた。また、
試料番号1及び2は、30時間加水分解を行っても遊離
リジン量が、14%に達しなかったので、その時点で加
水分解を終了した。
Test Example 6 This test was carried out in order to investigate the type of enzyme suitable for hydrolysis using flavor and antioxidant activity as indicators. 1) Preparation of samples Six types of samples were prepared by the same method as in Example 1 except that the type and addition amount of the enzyme used were changed as shown in Table 6. As the enzyme, an endopeptidase derived from Bacillus subtilis, bioplase 6.0S (manufactured by Nagase Seikagaku Co., Ltd.) and exopeptidase derived from lactic acid bacteria were prepared by the same method as in Reference Example 1 described below. Lactobacillus helveticus crushed cells or Bifidobacterium previs crushed cells, other endopeptidases, trypsin (manufactured by Novo Nordisk), and other exopeptidases, Denatim AP (Nagase Sangyo) (Manufactured by the company) was used. Also,
Since the free lysine amount of Sample Nos. 1 and 2 did not reach 14% even after 30 hours of hydrolysis, the hydrolysis was terminated at that time.

【0059】2)試験方法 風味及び抗酸化活性は、いずれも前記の方法により求め
た。
2) Test method Both the flavor and the antioxidant activity were determined by the above-mentioned methods.

【0060】3)試験結果 この試験の結果は、表6に示すとおりである。表6から
明らかなように風味が良くかつα−トコフェロールと同
等又はそれ以上の抗酸化活性を有する乳清蛋白質分解物
は、バシラス・サチリス由来のエンドペプチダーゼ及び
乳酸菌由来のエキソペプチダーゼの2種類の蛋白分解酵
素で加水分解したものであることが判明した。尚、乳清
蛋白質の種類、酵素の種類及び量を変更(バシラス・サ
チリス由来のエンドペプチダ−ゼ及び乳酸菌由来のエキ
ソペプチダ−ゼについては、前記する試験例3において
求められた範囲内で、その酵素量を変更)して試験した
が、ほぼ同様の結果が得られた。
3) Test Results The results of this test are shown in Table 6. As is clear from Table 6, whey protein hydrolyzate having a good flavor and an antioxidant activity equivalent to or higher than that of α-tocopherol is two types of proteins, an endopeptidase derived from Bacillus subtilis and an exopeptidase derived from lactic acid bacteria. It was found to be hydrolyzed with a degrading enzyme. The type of whey protein and the type and amount of the enzyme were changed (for the endopeptidase derived from Bacillus subtilis and the exopeptidase derived from lactic acid bacterium, the amount of enzyme was changed within the range determined in Test Example 3 described above. Was changed) and tested, but almost the same results were obtained.

【0061】[0061]

【表6】 [Table 6]

【0062】参考例1 コーンスティープリカー20部(重量。以下同じ)に水
道水100部及び石灰5部を添加し、コーンスティープ
リカーに含まれている酸を中和し、濾過助剤としてセラ
イト50部を添加して濾過し、濾液Aを得た。これとは
別に、フィシュリバー20部、モラセス35部及び水道
水200部の混合液にセライト50部を添加して濾過
し、濾液Bを得た。
Reference Example 1 100 parts of tap water and 5 parts of lime were added to 20 parts of corn steep liquor (weight, the same applies hereinafter) to neutralize the acid contained in the corn steep liquor, and Celite 50 as a filter aid. And then filtered to obtain a filtrate A. Separately from this, 50 parts of Celite was added to a mixed solution of 20 parts of fish river, 35 parts of molasses and 200 parts of tap water and filtered to obtain a filtrate B.

【0063】前記濾液A及び濾液Bの当量混合液500
部にグルコース5部、リン酸一カリウム2.5部、リン
酸二カリウム2.5部及び酢酸ナトリウム5部を添加
し、30%水酸化ナトリウムでpHを6.4に調整し、
水を添加して1000部に調整した。
Equivalent mixture 500 of the above-mentioned filtrate A and filtrate B
5 parts glucose, 2.5 parts potassium monophosphate, 2.5 parts dipotassium phosphate and 5 parts sodium acetate were added to the parts, and the pH was adjusted to 6.4 with 30% sodium hydroxide,
Water was added to adjust to 1000 parts.

【0064】滅菌した前記組成の培地10リッタ−にラ
クトバチルス・ヘルベティカスを培養し、得られた培養
液を遠心分離して乳酸菌菌体を回収し、滅菌水に菌体を
懸濁し、遠心分離して乳酸菌菌体を回収する操作を2回
反復して菌体を洗浄し、のち20%の濃度で菌体を滅菌
水に懸濁し、超音波破砕機(ブランソン社製。SONIFIER
model250)により菌体を破砕し、凍結乾燥し、乳酸菌
由来のエキソペプチダーゼ粉末約25gを得た。
Lactobacillus helveticus was cultivated in 10 liters of the sterilized medium having the above composition, and the obtained culture solution was centrifuged to collect the lactic acid bacteria cells, and the cells were suspended in sterile water and centrifuged. The procedure of recovering lactic acid bacterium cells is repeated twice to wash the microbial cells, and then the microbial cells are suspended in sterilized water at a concentration of 20%, and then ultrasonically disrupted (Branson Corp. SONIFIER
The cells were crushed according to model 250) and freeze-dried to obtain about 25 g of lactic acid bacterium-derived exopeptidase powder.

【0065】参考例2 実施例2と同一の方法で得た乳清蛋白加水分解物(蛋白
質等量79.4%)25.0kgを水140kgに溶解
し、5kgの水に溶解した所定量のミネラル類を加え、
60℃に加熱し、DHA70gを含む植物性脂肪2.0
kg、マルツデキストリン65.1kg、砂糖6.6k
g及び所定量のビタミン類を混合し、この混合液を高圧
均質機で十分均質化し、120℃で2秒間殺菌し、噴霧
乾燥し、粉末状の抗アレルギー性組成物約99kgを得
た。
Reference Example 2 25.0 kg of a whey protein hydrolyzate (protein equivalent 79.4%) obtained by the same method as in Example 2 was dissolved in 140 kg of water, and a predetermined amount of the solution was dissolved in 5 kg of water. Add minerals,
Vegetable fat containing 70 g of DHA heated to 60 ° C 2.0
kg, malt dextrin 65.1kg, sugar 6.6k
g and a predetermined amount of vitamins were mixed, and this mixed solution was sufficiently homogenized by a high-pressure homogenizer, sterilized at 120 ° C. for 2 seconds, and spray-dried to obtain about 99 kg of a powdery antiallergic composition.

【0066】次に実施例を示して本発明を更に詳述する
が、本発明は以下の実施例に限定されるものではない。
Next, the present invention will be described in more detail by showing examples, but the present invention is not limited to the following examples.

【実施例】【Example】

実施例1 純度75%の乳清蛋白質粉末(カリフォルニア・プロテ
イン社製)1kgを、脱イオン水9kgに溶解し、75
℃に15秒間保持して殺菌し、pHを9.0に調整し、
プロテア−ゼNアマノ(天野製薬社製)180万PUN
単位(乳清蛋白質1g当たり2400PUN単位)及び
前記参考例1と同一の方法で調整したラクトバチルス・
ヘルベティカス菌体破砕物6.8万活性単位(乳清蛋白
質1g当たり90活性単位)を添加し、50℃に保持し
て加水分解し、バイオテックアナライザー(旭化成工業
社製)を用いて経時的に遊離リジンの量を測定し、遊離
リジン量が14%に達した時点で、80℃で6分間加熱
して酵素を失活させ、冷却し、のちクエン酸でpHを
6.0に調整し、分画分子量10,000の限外濾過膜
(日東電工社製)で限外濾過し、乳清蛋白質加水分解物
を5.9%含有する溶液約16kgを得た。
Example 1 1 kg of a whey protein powder having a purity of 75% (manufactured by California Protein Co.) was dissolved in 9 kg of deionized water to prepare 75
Sterilize by holding at ℃ for 15 seconds, adjust pH to 9.0,
Proteases N Amano (Amano Pharmaceutical Co., Ltd.) 1.8 million PUN
Units (2400 PUN units per 1 g of whey protein) and Lactobacillus prepared by the same method as in Reference Example 1
Helveticus cell disruption product (60,000 activity units (90 activity units per 1 g of whey protein)) was added, and the mixture was kept at 50 ° C to hydrolyze and then biotech analyzer (manufactured by Asahi Kasei Kogyo Co., Ltd.) was used. The amount of free lysine was measured, and when the amount of free lysine reached 14%, the enzyme was inactivated by heating at 80 ° C. for 6 minutes, cooled, and then the pH was adjusted to 6.0 with citric acid, Ultrafiltration was performed with an ultrafiltration membrane having a molecular weight cut-off of 10,000 (manufactured by Nitto Denko Corporation) to obtain about 16 kg of a solution containing 5.9% whey protein hydrolyzate.

【0067】得られた乳清蛋白質加水分解物を前記試験
方法により試験した結果の一部を図1、図2及び図3に
示す。これらの結果、乳清蛋白質加水分解物は、分子量
5,000〜10,000ダルトンの画分が、全加水分
解物の0.3%、抗原残存活性が10-6以下、リジンの
遊離率が14%、遊離アミノ酸含量11%、アンモニア
含有量が0.07%、10%溶液の透過率が98%、5
%溶液のpH未調整及びpH4における120℃、10
分間の加熱にも安定であり、α−トコフェロ−ルと同等
の抗酸化活性を有した。また、前記試験方法により試験
したアミノ酸組成(乳清蛋白加水分解物1g当たり)は
次のとおりであった。
Some of the results of the test of the obtained whey protein hydrolyzate by the above test method are shown in FIGS. 1, 2 and 3. As a result, in the whey protein hydrolyzate, the fraction having a molecular weight of 5,000 to 10,000 daltons has a total hydrolyzate content of 0.3%, an antigen residual activity of 10 -6 or less, and a lysine release rate. 14%, free amino acid content 11%, ammonia content 0.07%, 10% solution permeability 98%, 5
% Unadjusted pH of the solution and pH 4 at 120 ° C., 10
It was stable even after heating for a minute and had an antioxidant activity equivalent to that of α-tocopherol. The amino acid composition tested by the above test method (per 1 g of whey protein hydrolyzate) was as follows.

【0068】 L−アラニン 52.8(mg) L−アルギニン 23.4 L−アスパラギン酸(L−アスパラギンを含む)102.6 L−システイン 17.1 L−グルタミン酸(L−グルタミンを含む) 185.1 L−グリシン 18.8 L−ヒスチジン 17.7 L−イソロイシン 59.9 L−ロイシン 100.1 L−リジン 94.6 L−メチオニン 15.8 L−フェニルアラニン 29.5 L−プロリン 61.4 L−セリン 49.2 L−スレオニン 70.3 L−トリプトファン 16.7 L−チロシン 26.1 L−バリン 54.7L-alanine 52.8 (mg) L-arginine 23.4 L-aspartic acid (including L-asparagine) 102.6 L-cysteine 17.1 L-glutamic acid (including L-glutamine) 185. 1 L-glycine 18.8 L-histidine 17.7 L-isoleucine 59.9 L-leucine 100.1 L-lysine 94.6 L-methionine 15.8 L-phenylalanine 29.5 L-proline 61.4 L -Serine 49.2 L-threonine 70.3 L-tryptophan 16.7 L-tyrosine 26.1 L-valine 54.7

【0069】実施例2 純度85%の乳清蛋白質粉末(デンマーク・プロテイン
社製)1kgを、脱イオン水19kgに溶解し、pHを
10に調整し、市販のトリプシン(ノボノルディスク社
製)を11万PUN単位(乳清蛋白質1g当たり130
PUN単位)、プロテア−ゼNアマノ(天野製薬社製)
180万PUN単位(乳清蛋白質1g当たり2100P
UN単位)及び前記参考例1と同様の方法で調整したラ
クトバチルス・ブルガリカス菌体破砕物5.1万活性単
位(乳清蛋白質1g当たり60活性単位)を添加し、4
0℃で加水分解し、バイオテックアナライザー(旭化成
工業社製)を用いて経時的に遊離リジンの量を測定し、
遊離リジン量が17%に達した時点で、130℃で2秒
間加熱して酵素を失活させ、冷却し、のちクエン酸でp
Hを6.5に調整し、分画分子量3,000の限外濾過
膜(旭化成工業社製)で限外濾過し、濃縮し、噴霧乾燥
し、粉末状の乳清蛋白質加水分解物約800gを得た。
Example 2 1 kg of 85% pure whey protein powder (manufactured by Denmark Protein Co.) was dissolved in 19 kg of deionized water to adjust the pH to 10, and commercially available trypsin (manufactured by Novo Nordisk Co.) was used. 110,000 PUN units (130 per gram of whey protein
PUN unit), Protease N Amano (manufactured by Amano Pharmaceutical Co., Ltd.)
1.8 million PUN units (2100P per gram of whey protein)
UN units) and 51,000 active units of Lactobacillus bulgaricus crushed cells prepared by the same method as in Reference Example 1 (60 active units per 1 g of whey protein) were added, and 4
It is hydrolyzed at 0 ° C., and the amount of free lysine is measured with time using a Biotech analyzer (manufactured by Asahi Kasei Corporation).
When the amount of free lysine reached 17%, the enzyme was inactivated by heating at 130 ° C. for 2 seconds, cooled, and then added with citric acid.
H was adjusted to 6.5, ultrafiltered with an ultrafiltration membrane having a molecular weight cut off of 3,000 (manufactured by Asahi Chemical Industry Co., Ltd.), concentrated, spray-dried, and powdered whey protein hydrolyzate about 800 g Got

【0070】得られた乳清蛋白質加水分解物を前記の試
験方法により試験した結果、分子量5,000〜10,
000ダルトンの画分が、全加水分解物の0.2%、抗
原残存活性が10-6以下、リジンの遊離率が17%、遊
離アミノ酸含量13%、アンモニア含有量が0.04
%、10%溶液の透過率が99%、5%溶液のpH未調
整及びpH4における120℃、10分間の加熱にも安
定であり、α−トコフェロ−ルと同等の抗酸化活性を有
した。
The obtained whey protein hydrolyzate was tested by the above-mentioned test method, and as a result, the molecular weight was 5,000 to 10,
The fraction of 000 daltons has a total hydrolyzate content of 0.2%, an antigen residual activity of 10 -6 or less, a lysine release rate of 17%, a free amino acid content of 13%, and an ammonia content of 0.04.
%, The transmittance of the 10% solution was 99%, the pH of the 5% solution was not adjusted, and it was stable even when heated at 120 ° C. for 10 minutes at pH 4, and had an antioxidant activity equivalent to that of α-tocopherol.

【0071】実施例3 純度90%の乳清蛋白質粉末(バイオポール社製)1k
gを、脱イオン水19kgに溶解し、75℃に15秒間
保持して殺菌し、pHを8.0に調整し、市販のパパイ
ン(天野製薬社製)を10万PUN単位(乳清蛋白質1
g当たり110PUN単位)、ニュートラーゼ(ノボノ
ルディスク社製)220万PUN単位(乳清蛋白質1g
当たり2400PUN単位)及び前記参考例1と同様の
方法で調整したビフィドバクテリウム・プレビス菌体破
砕物9万活性単位(乳清蛋白質1g当たり100活性単
位)を添加し、50℃に保持して加水分解し、バイオテ
ックアナライザー(旭化成工業社製)を用いて経時的に
遊離リジンの量を測定し、遊離リジン量が20%に達し
た時点で、85℃で15分間加熱して酵素を失活させ、
冷却し、のちクエン酸でpHを7.0に調整し、分画分
子量10,000の限外濾過膜(日東電工社製)で限外
濾過し、濃縮し、噴霧乾燥し、粉末状の乳清蛋白質加水
分解物約800gを得た。
Example 3 Whey protein powder having a purity of 90% (manufactured by Biopol) 1k
g was dissolved in 19 kg of deionized water, sterilized by holding at 75 ° C. for 15 seconds, the pH was adjusted to 8.0, and commercially available papain (manufactured by Amano Pharmaceutical Co., Ltd.) was added to 100,000 PUN units (whey protein 1
110 PUN units per g), Neutrase (Novo Nordisk) 2.2 million PUN units (whey protein 1 g)
(2400 PUN units per 1) and Bifidobacterium prebis crushed product 90,000 active units (100 active units per 1 g of whey protein) prepared by the same method as in Reference Example 1 above, and kept at 50 ° C. After hydrolysis, the amount of free lysine was measured with time using a Biotech analyzer (manufactured by Asahi Kasei Co., Ltd.), and when the amount of free lysine reached 20%, it was heated at 85 ° C for 15 minutes to lose the enzyme. Let it live
After cooling, the pH is adjusted to 7.0 with citric acid, ultrafiltered with an ultrafiltration membrane with a molecular weight cut-off of 10,000 (manufactured by Nitto Denko), concentrated, spray-dried and powdered milk. About 800 g of clear protein hydrolyzate was obtained.

【0072】得られた乳清蛋白質加水分解物を前記試験
方法により試験した結果、分子量5,000〜10,0
00ダルトンの画分が、全加水分解物の0.3%、抗原
残存活性が10-6以下、リジンの遊離率が20%、遊離
アミノ酸含量15%、アンモニア含有量が0.09%、
10%溶液の透過率が98%、5%溶液のpH未調整及
びpH4における120℃、10分間の加熱にも安定で
あり、α−トコフェロ−ルと同等の抗酸化活性を有し
た。
The whey protein hydrolyzate thus obtained was tested by the above-mentioned test method, and as a result, a molecular weight of 5,000 to 10,0 was obtained.
The fraction of 00 daltons is 0.3% of the total hydrolyzate, the residual antigen activity is 10 -6 or less, the lysine release rate is 20%, the free amino acid content is 15%, the ammonia content is 0.09%,
The transmittance of the 10% solution was 98%, it was stable even when the pH of the 5% solution was unadjusted and heated at 120 ° C for 10 minutes at pH 4, and it had an antioxidant activity equivalent to that of α-tocopherol.

【0073】実施例4 純度70%の乳清蛋白質粉末(ミライ社製)1kgを、
脱イオン水5.7kgに溶解し、pHを9.0に調整
し、ビオプラーゼ6.0S(長瀬生化学工業社製)16
0万PUN単位(乳清蛋白質1g当たり2000PUN
単位)及び前記参考例1と同様の方法で調整したストレ
プトコッカス・ラクチス菌体破砕物6.3万活性単位
(乳清蛋白質1g当たり90活性単位)を添加し、45
℃で加水分解し、バイオテックアナライザー(旭化成工
業社製)を用いて経時的に遊離リジンの量を測定し、遊
離リジン量が19%に達した時点で、130℃で2秒間
加熱して酵素を失活させ、冷却し、のちクエン酸でpH
を7.0に調整し、分画分子量10,000の限外濾過
膜(旭化成社製)で限外濾過し、乳清蛋白質加水分解物
を8.4%含有する溶液約11kgを得た。
Example 4 1 kg of whey protein powder having a purity of 70% (manufactured by Mirai Co.)
Dissolved in 5.7 kg of deionized water, adjusted the pH to 9.0, and used bioprase 6.0S (Nagase Seikagaku Corporation) 16
0,000 PUN units (2000 PUN per 1 g of whey protein)
Unit) and 63,000 active units of Streptococcus lactis crushed product prepared in the same manner as in Reference Example 1 (90 active units per 1 g of whey protein), and
After hydrolyzing at ℃, the amount of free lysine was measured with time using a Biotech analyzer (manufactured by Asahi Kasei Co., Ltd.), and when the amount of free lysine reached 19%, the mixture was heated at 130 ° C. for 2 seconds and the enzyme was added. Deactivate, cool, and then pH with citric acid
Was adjusted to 7.0 and subjected to ultrafiltration with an ultrafiltration membrane having a molecular weight cut off of 10,000 (manufactured by Asahi Kasei) to obtain about 11 kg of a solution containing 8.4% whey protein hydrolyzate.

【0074】得られた乳清蛋白質加水分解物を前記の試
験方法により試験した結果、分子量5,000〜10,
000ダルトンの画分が、全加水分解物の0.9%、抗
原残存活性が10-6以下、リジンの遊離率が19%、遊
離アミノ酸含量14.5%、アンモニア含有量が0.1
0%、10%溶液の透過率が98%、5%溶液のpH未
調整及びpH4における120℃、10分間の加熱にも
安定であり、α−トコフェロ−ルと同等の抗酸化活性を
有した。
The obtained whey protein hydrolyzate was tested by the above-mentioned test method, and as a result, a molecular weight of 5,000 to 10,
The fraction of 000 Dalton is 0.9% of total hydrolyzate, the residual antigen activity is 10 -6 or less, the lysine release rate is 19%, the free amino acid content is 14.5%, and the ammonia content is 0.1.
The transmittance of the 0% and 10% solutions was 98%, it was stable even when the pH of the 5% solution was unadjusted and heated at 120 ° C. for 10 minutes at pH 4, and had an antioxidant activity equivalent to that of α-tocopherol. .

【0075】実施例5 純度80%の乳清蛋白質粉末(ニュージーランド・デー
リー・ボード製)1kgを、脱イオン水12.3kgに
溶解し、75℃に15秒間保持して殺菌し、pHを8.
5に調整し、市販のパパイン(天野製薬社製)を8万P
UN単位(乳清蛋白質1g当たり100PUN単位)、
ビオプラーゼ(長瀬生化学工業社製)220万PUN単
位(乳清蛋白質1g当たり2700PUN単位)及び前
記参考例1と同様の方法で調整したストレプトコッカス
・クレモリス菌体破砕物5.6万活性単位(乳清蛋白質
1g当たり70活性単位)を添加し、pHを6.5に保
持して55℃で加水分解し、バイオテックアナライザー
(旭化成工業社製)を用いて経時的に遊離リジンの量を
測定し、遊離リジン量が17%に達した時点で、90℃
で5分間加熱して酵素を失活させ、冷却し、のちクエン
酸でpHを5.5に調整し、分画分子量10,000の
限外濾過膜(日東電工社製)で限外濾過し、濃縮し、噴
霧乾燥し、粉末状の乳清蛋白質加水分解物約800gを
得た。
Example 5 1 kg of whey protein powder having a purity of 80% (manufactured by New Zealand Daily Board) was dissolved in 12.3 kg of deionized water and kept at 75 ° C. for 15 seconds for sterilization to adjust the pH to 8.
Adjusted to 5, commercial papain (Amano Pharmaceutical Co., Ltd.) 80,000P
UN units (100 PUN units per 1 g of whey protein),
Biopulase (manufactured by Nagase Seikagaku Co., Ltd.) 2.2 million PUN units (2700 PUN units per 1 g of whey protein) and Streptococcus cremoris cell disruption product 56,000 active units (whey) prepared in the same manner as in Reference Example 1 above. (70 activity units per 1 g of protein) was added, the pH was kept at 6.5, hydrolysis was carried out at 55 ° C., and the amount of free lysine was measured with time using a Biotech Analyzer (Asahi Kasei Co., Ltd.). When the amount of free lysine reaches 17%, 90 ° C
The mixture is heated for 5 minutes to inactivate the enzyme, cooled, then adjusted to pH 5.5 with citric acid, and ultrafiltered with an ultrafiltration membrane (Nitto Denko) with a molecular weight cutoff of 10,000. After concentrating and spray-drying, about 800 g of powdery whey protein hydrolyzate was obtained.

【0076】得られた乳清蛋白質加水分解物を前記試験
方法により試験した結果、分子量5,000〜10,0
00ダルトンの画分が、全加水分解物の0.3%、抗原
残存活性が10-6以下、リジンの遊離率が17%、遊離
アミノ酸含量13%、アンモニア含有量が0.11%、
10%溶液の透過率が99%、5%溶液のpH未調整及
びpH4における120℃、10分間の加熱にも安定で
あり、α−トコフェロ−ルと同等の抗酸化活性を有し
た。
The obtained whey protein hydrolyzate was tested by the above-mentioned test method, and as a result, the molecular weight was 5,000 to 10,0.
The fraction of 00 daltons is 0.3% of the total hydrolyzate, the residual antigen activity is 10 -6 or less, the lysine release rate is 17%, the free amino acid content is 13%, the ammonia content is 0.11%,
The transmittance of the 10% solution was 99%, the pH of the 5% solution was unadjusted, and it was stable even when heated at 120 ° C for 10 minutes at pH 4, and had an antioxidant activity equivalent to that of α-tocopherol.

【0077】実施例6 純度70%の乳清蛋白質粉末(カリフォルニア・プロテ
イン社製)1kgを、脱イオン水7kgに溶解し、pH
を8.0に調整し、ブロメライン(天野製薬社製)35
万PUN単位(乳清蛋白質1g当たり500PUN単
位)、ニュートラーゼ(ノボノルディスク社製)230
万PUN単位(乳清蛋白質1g当たり3300PUN単
位)及び前記参考例1と同様の方法で調整したラクトバ
チルス・ブルガリカス菌体破砕物5.6万活性単位(乳
清蛋白質1g当たり80活性単位)を添加し、47℃で
加水分解し、バイオテックアナライザー(旭化成工業社
製)を用いて経時的に遊離リジンの量を測定し、遊離リ
ジン量が17%に達した時点で、85℃で15分間加熱
して酵素を失活させ、冷却し、のちクエン酸でpHを
5.5に調整し、分画分子量10,000の限外瀘過膜
(日東電工社製)で限外濾過し、濃縮し、噴霧乾燥し、
粉末状の乳清蛋白質加水分解物約800gを得た。
Example 6 1 kg of whey protein powder having a purity of 70% (California Protein Co., Ltd.) was dissolved in 7 kg of deionized water to adjust the pH.
Was adjusted to 8.0 and bromelain (manufactured by Amano Pharmaceutical Co., Ltd.) 35
10,000 PUN units (500 PUN units per 1 g of whey protein), Neutrase (Novo Nordisk) 230
10,000 PUN units (3300 PUN units per 1 g of whey protein) and 56,000 active units of Lactobacillus bulgaricus cell disrupted product (80 active units per 1 g of whey protein) prepared by the same method as in Reference Example 1 above. Add, hydrolyze at 47 ° C, measure the amount of free lysine over time using a Biotech analyzer (Asahi Kasei), and when the amount of free lysine reaches 17%, at 85 ° C for 15 minutes Heat to inactivate the enzyme, cool, and then adjust the pH to 5.5 with citric acid, ultrafilter with an ultrafiltration membrane (Nitto Denko) with a cut-off molecular weight of 10,000, and concentrate. Spray dried
About 800 g of powdery whey protein hydrolyzate was obtained.

【0078】得られた乳清蛋白質加水分解物を前記の試
験方法により試験した結果、分子量5,000〜10,
000ダルトンの画分が、全加水分解物の0.4%、抗
原残存活性が10-6以下、リジンの遊離率が17%、遊
離アミノ酸含量13%、アンモニア含有量が0.10
%、10%溶液の透過率が98%、5%溶液のpH未調
整及びpH4における120℃、10分間の加熱にも安
定であった。
The obtained whey protein hydrolyzate was tested by the above-mentioned test method, and as a result, a molecular weight of 5,000 to 10,
The 000 Dalton fraction contained 0.4% of total hydrolyzate, residual antigen activity of 10 -6 or less, lysine release rate of 17%, free amino acid content of 13%, and ammonia content of 0.10.
%, The transmittance of the 10% solution was 98%, the pH of the 5% solution was not adjusted, and the pH was stable at 120 ° C. for 10 minutes at pH 4.

【0079】実施例7 純度80%の乳清蛋白質粉末(デンマーク・プロテイン
社製)1kgを、脱イオン水9kgに溶解し、pHを
7.5に調整し、市販のニュートラーゼ(ノボノルディ
スク社製)を160万PUN単位(乳清蛋白質1g当た
り2000PUN単位)及び前記参考例1と同様の方法
で調整したビフィドバクテリウム・プレビス菌体破砕物
2.8万活性単位(乳清蛋白質1g当たり35活性単
位)を添加し、pH7.5に保持して45℃で加水分解
し、バイオテックアナライザー(旭化成工業社製)を用
いて経時的に遊離リジンの量を測定し、遊離リジン量が
12%に達した時点で、90℃で20分間加熱して酵素
を失活させ、冷却し、のちクエン酸でpHを7.0に調
整し、分画分子量3,000の限外濾過膜(旭化成社
製)で限外濾過し、濃縮し、噴霧乾燥し、粉末状の乳清
蛋白質加水分解物約800gを得た。
Example 7 1 kg of whey protein powder having a purity of 80% (manufactured by Protein Co., Denmark) was dissolved in 9 kg of deionized water to adjust the pH to 7.5, and a commercially available Neutrase (Novo Nordisk Co.) was used. Manufactured) by 1.6 million PUN units (2000 PUN units per 1 g of whey protein) and 28,000 active units of Bifidobacterium previs crushed cells prepared by the same method as in Reference Example 1 (per 1 g of whey protein) 35 activity units) was added, and the mixture was kept at pH 7.5 and hydrolyzed at 45 ° C., and the amount of free lysine was measured with time using a Biotech analyzer (Asahi Kasei Co., Ltd.). %, The enzyme was inactivated by heating at 90 ° C. for 20 minutes, cooled, and then the pH was adjusted to 7.0 with citric acid, and an ultrafiltration membrane with a molecular weight cutoff of 3,000 (Asahi Kasei Company ), Ultrafiltrate, concentrate and spray dry to obtain about 800 g of powdery whey protein hydrolyzate.

【0080】得られた乳清蛋白質加水分解物を前記試験
方法により試験した結果、分子量5,000〜10,0
00ダルトンの画分が、全加水分解物の0.4%、抗原
残存活性が10-6以下、リジンの遊離率が12%、遊離
アミノ酸含量10%、アンモニア含有量が0.09%、
10%溶液の透過率が100%、5%溶液のpH未調整
及びpH4における120℃、10分間の加熱にも安定
であった。
The obtained whey protein hydrolyzate was tested by the above-mentioned test method, and as a result, the molecular weight was 5,000 to 10,0.
The fraction of 00 dalton is 0.4% of total hydrolyzate, the residual antigen activity is 10 -6 or less, the liberation rate of lysine is 12%, the free amino acid content is 10%, the ammonia content is 0.09%,
The transmittance of the 10% solution was 100%, the pH of the 5% solution was unadjusted, and the pH was stable at 120 ° C. for 10 minutes at pH 4.

【0081】[0081]

【発明の効果】以上詳述したように本発明は、風味良好
な乳清蛋白加水分解物及びその製造法であり、本発明に
よって奏せられる効果は、次のとおりである。 1)本発明の乳清蛋白質加水分解物は、腸管吸収性にお
いて優れ、アミノ酸バランスが良好なので、消化吸収能
の未熟な乳幼児又は消化吸収能が低下している高齢者、
病人への蛋白質供給源用素材として使用できる。 2)本発明の乳清蛋白質加水分解物は、抗原残存活性が
ないので、アレルギー患者、アレルギー予防を目的とし
て乳幼児、妊産婦、免疫機能の低下した病人への蛋白質
供給源用素材として使用できる。 3)本発明の乳清蛋白質加水分解物は、抗酸化作用を有
し、熱安定性、透明性も高く、風味良好なので母乳強化
組成物や経口経腸栄養剤の蛋白質供給源用素材として使
用できる。 4)本発明の方法により、広範な用途を有する乳清蛋白
質加水分解物を製造することができる。
As described in detail above, the present invention is a whey protein hydrolyzate having a good flavor and a method for producing the same, and the effects of the present invention are as follows. 1) Since the whey protein hydrolyzate of the present invention is excellent in intestinal absorbability and has a good amino acid balance, an infant who is immature in digestion and absorption ability or an elderly person whose digestion and absorption ability is reduced,
It can be used as a protein source material for the sick. 2) Since the whey protein hydrolyzate of the present invention has no residual antigen activity, it can be used as a material for protein supply to infants, pregnant women, and sick people with reduced immune function for the purpose of allergy patients and allergy prevention. 3) The whey protein hydrolyzate of the present invention has an antioxidant effect, has high heat stability and transparency, and has a good flavor, and thus is used as a material for a protein source of a milk fortified composition or an oral enteral nutritional supplement. it can. 4) By the method of the present invention, a whey protein hydrolyzate having a wide range of uses can be produced.

【図面の簡単な説明】[Brief description of drawings]

【図1】本発明の乳清蛋白加水分解物の分子量分布を示
す。
FIG. 1 shows the molecular weight distribution of the whey protein hydrolyzate of the present invention.

【図2】本発明の乳清蛋白加水分解物の抗原残存活性を
示す。
FIG. 2 shows the residual antigen activity of the whey protein hydrolyzate of the present invention.

【図3】本発明の乳清蛋白加水分解物の抗酸化活性を示
す。
FIG. 3 shows the antioxidant activity of the whey protein hydrolyzate of the present invention.

─────────────────────────────────────────────────────
─────────────────────────────────────────────────── ───

【手続補正書】[Procedure amendment]

【提出日】平成7年3月9日[Submission date] March 9, 1995

【手続補正1】[Procedure Amendment 1]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】0028[Correction target item name] 0028

【補正方法】変更[Correction method] Change

【補正内容】[Correction content]

【0028】b)図2に示すとおり、抗乳清蛋白質血清
を用いたエライザ抑制試験法により測定した抗原残存活
性が10−5以下、望ましくは10−6以下である。図
2は、実施例1により得られた本発明の乳清蛋白加水分
解物の抗原残存活性を示し、縦軸及び横軸は、それぞれ
抑制割合及び最終試料濃度を示す。図中+及び□は、そ
れぞれ本発明の乳清蛋白分解物及び乳清蛋白質を示す。
B) As shown in FIG. 2, the residual antigen activity measured by the ELISA inhibition test method using anti-whey protein serum is 10 -5 or less, preferably 10 -6 or less. FIG. 2 shows the antigen residual activity of the whey protein hydrolyzate of the present invention obtained in Example 1, and the vertical axis and the horizontal axis show the inhibition rate and the final sample concentration, respectively. In the figure, + and □ represent the whey protein degradation product and whey protein of the present invention , respectively.

【手続補正書】[Procedure amendment]

【提出日】平成7年12月13日[Submission date] December 13, 1995

【手続補正1】[Procedure Amendment 1]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】0005[Name of item to be corrected] 0005

【補正方法】変更[Correction method] Change

【補正内容】[Correction content]

【0005】一方、摂取したアミノ酸がトランスグルタ
ミナーゼ、グルタメートデヒトロゲナーゼ等によって分
解されて、アンモニアが生成するが、生成したアンモニ
アは有毒であり、肝臓で直ちに処理される必要があり、
摂取する食品にアンモニアが含有されていないことが必
要である。このような点から、乳清蛋白加水分解物に
も、アンモニアが含有されていないことが、極めて重要
である。
On the other hand, the ingested amino acid is decomposed by transglutaminase, glutamate dehidrogenase and the like to produce ammonia, which is toxic and needs to be immediately treated in the liver.
It is necessary that the food you eat does not contain ammonia. From this point, it is extremely important that the whey protein hydrolyzate does not contain ammonia.

【手続補正2】[Procedure Amendment 2]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】0012[Correction target item name] 0012

【補正方法】変更[Correction method] Change

【補正内容】[Correction content]

【0012】5)牛乳蛋白質をトリプシン、α−キモト
リプシン、アスペルギルス属、バシラス属菌の酵素で分
解し、分子量10,000ダルトン以下の経口免疫寛容
誘導能を有する低アレルゲン性ペプチドが開示されてい
る(特開平5−5000号公報)。
5) A low allergenic peptide having a molecular weight of 10,000 daltons or less and having an oral tolerance- inducing ability, which is obtained by decomposing a milk protein with enzymes of trypsin, α-chymotrypsin, Aspergillus and Bacillus. (Japanese Patent Laid-Open No. 5-5000).

【手続補正3】[Procedure 3]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】0013[Correction target item name] 0013

【補正方法】変更[Correction method] Change

【補正内容】[Correction content]

【0013】6)カゼインを酸性プロテアーゼで分解
し、中性でペプチダーゼで分解し、分子量3,000ダ
ルトン以下、遊離アミノ酸含量30〜55%、α−カ
ゼインに対するELISA抑制試験がα−カゼインの
10,000分の1以下、5%溶液の苦味官能値がカフ
ェイン0.04%水溶液相当以下のペプチドが開示され
ている(特開平6−113893号公報)。
[0013] 6) casein digested with acid protease, decomposes at peptidase at neutral, the molecular weight of 3,000 daltons or less, free amino acid content 30~55%, α S - ELISA inhibition test against casein alpha S - casein A peptide having a bitterness functional value of a 10,000% or less and a 5% solution corresponding to a caffeine 0.04% aqueous solution or less is disclosed (JP-A-6-113893).

【手続補正4】[Procedure amendment 4]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】0032[Name of item to be corrected] 0032

【補正方法】変更[Correction method] Change

【補正内容】[Correction content]

【0032】(2)抗原残存活性の測定方法ELISA抑制 試験法(日本小児アレルギー学会誌、第
1巻、第36ページ、1978年)により次のようにし
て測定した。96穴プレート(ヌンク社製)に乳清蛋白
質をコーティングし、洗浄し、ウサギ抗乳清蛋白質血清
及び加水分解物試料の混合液をプレートの穴に供給して
反応させ、洗浄後アルカリホスファターゼ標識ヤギ抗ウ
サギIgG抗体(ザイメッド・ラボラトリー社製)を反
応させ、洗浄後p−ニトロフェニル・リン酸ナトリウム
を添加し、30分後に5N水酸化ナトリウムを添加して
反応を停止させ、反応生成物をマイクロプレートリーダ
ー(和光純薬工業社製)で測定した。なお、抑制用被検
抗原液添加による反応抑制の程度の表現には次の式で算
出した抑制率を用いた。 抑制率(%)=(1−被検抗原液での吸光度/対照の吸
光度)×100 ただし、被検抗原液の吸光度及び対照の吸光度は抗乳清
蛋白血清にそれぞれ等量の被検試料液又は希釈液の混合
液を入れた穴の反応後測定した値である。
(2) Method for measuring residual antigen activity The measurement was carried out as follows by the ELISA inhibition test method (Journal of Japanese Society of Pediatric Allergy, Vol. 1, p. 36, 1978). 96-well plate (manufactured by Nunc) is coated with whey protein and washed, and a mixture of rabbit anti-whey protein serum and hydrolyzate sample is supplied to the well of the plate to react, and after washing, alkaline phosphatase-labeled goat Anti-rabbit IgG antibody (manufactured by Zymed Laboratories) was reacted, and after washing, p-nitrophenyl sodium phosphate was added, and after 30 minutes, 5N sodium hydroxide was added to stop the reaction, and the reaction product was micronized. It measured with the plate reader (made by Wako Pure Chemical Industries Ltd.). In addition, the suppression rate calculated by the following formula was used to express the degree of reaction suppression by the addition of the test antigen solution for suppression. Inhibition rate (%) = (1-absorbance of test antigen solution / absorbance of control) x 100 However, the absorbance of the test antigen solution and the absorbance of the control are the same as the test sample solution of anti-whey protein serum. Alternatively, it is a value measured after the reaction of the hole in which the mixed liquid of the diluting liquid is put.

【手続補正5】[Procedure Amendment 5]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】0033[Correction target item name] 0033

【補正方法】変更[Correction method] Change

【補正内容】[Correction content]

【0033】(3)アミノ酸組成の測定方法 トリプトファン、システイン及びメチオニン以外のアミ
ノ酸については、試料を6N塩酸で110℃、24時間
加水分解し、トリプトファンについては、水酸化バリウ
ムで110℃、22時間アルカリ分解し、システイン及
びメチオニンについては、過ぎ酸処理後6N塩酸で11
0℃、18時間加水分解し、それぞれアミノ酸分析機
(日立製作所製。835型)により分析し、アミノ酸の
質量を測定した。
(3) Method for measuring amino acid composition For amino acids other than tryptophan, cysteine and methionine, samples were hydrolyzed with 6N hydrochloric acid at 110 ° C. for 24 hours, and for tryptophan, barium hydroxide at 110 ° C. for 22 hours. After decomposition, cysteine and methionine were treated with 6N hydrochloric acid after the treatment with excess acid.
0 ° C., 18 hours to hydrolyze, and analyzed by each amino acid analyzer (Hitachi, Ltd. .835 inch), the mass was measured amino acid.

【手続補正6】[Procedure correction 6]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】0035[Correction target item name] 0035

【補正方法】変更[Correction method] Change

【補正内容】[Correction content]

【0035】(5)遊離リジン含量の測定方法 リジン測定用酵素電極、20mML−リジン標準液、
0.1M燐酸L−リジン測定用緩衝液及び洗浄用界面活
性剤(いずれも旭化成工業社製)を用い、バイオテック
アナライザー(旭化成工業社製)により遊離リジン濃度
をバッチ式又はオンラインで測定し、乳清蛋白質のリジ
ン含有量に対する分解溶液の遊離リジン含有量から全リ
ジンに対する遊離リジンの量の割合を算出した。
(5) Method for measuring free lysine content Enzyme electrode for lysine measurement, 20 mM L-lysine standard solution,
Using a 0.1 M L-lysine phosphate measurement buffer and a washing surfactant (both manufactured by Asahi Kasei Kogyo Co., Ltd.), the free lysine concentration was measured in a batch or online with a Biotech analyzer (Asahi Kasei Kogyo Co., Ltd.), The ratio of the amount of free lysine to the total lysine was calculated from the free lysine content of the decomposition solution to the lysine content of whey protein.

【手続補正7】[Procedure Amendment 7]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】0049[Correction target item name] 0049

【補正方法】変更[Correction method] Change

【補正内容】[Correction content]

【0049】[0049]

【表3】 [Table 3]

【手続補正8】[Procedure Amendment 8]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】0058[Name of item to be corrected] 0058

【補正方法】変更[Correction method] Change

【補正内容】[Correction content]

【0058】試験例6 この試験は、風味と抗酸化活性を指標として、加水分解
のために好適な酵素の種類を調べるために行った。 1)試料の調製 表6に示すとおり使用する酵素の種類及び添加量を変更
したことを除き、実施例1と同一の方法により6種類の
試料を調製した。なお、酵素としては、バシラス・サチ
リス由来のエンドペプチダーゼとして、ビオプラーゼ
6.0S(長瀬生化学工業社製)、乳酸菌由来のエキソ
ペプチダーゼとして、後記する参考例1と同様の方法で
調製したラクトバシラス・ヘルベティカス菌体破砕物又
はビフィドバクテリウム・ブレーベ菌体破砕物、その他
のエンドペプチダーゼとして、トリプシン(ノボノルデ
ィスク社製)、及ひその他のエキソペプチダーゼとし
て、デナチームAP(長瀬産業社製)を用いた。また、
試料番号1及び2は、30時間加水分解を行っても遊離
リジン量が、14%に達しなかったので、その時点で加
水分解を終了した。
Test Example 6 This test was carried out in order to investigate the type of enzyme suitable for hydrolysis using flavor and antioxidant activity as indicators. 1) Preparation of samples Six types of samples were prepared by the same method as in Example 1 except that the type and addition amount of the enzyme used were changed as shown in Table 6. As the enzyme, biopulase 6.0S (manufactured by Nagase Seikagaku Corporation) as endopeptidase derived from Bacillus subtilis, and exopeptidase derived from lactic acid bacterium were used in the same manner as in Reference Example 1 described later.
Lactobacillus helveticus disrupted cells were prepared or Bifidobacterium breve disrupted cells, as other endopeptidase, trypsin (manufactured by Novo Nordisk), as及Hi other exopeptidase, Denachimu AP (Nagase Co. Manufactured) was used. Also,
Since the free lysine amount of Sample Nos. 1 and 2 did not reach 14% even after 30 hours of hydrolysis, the hydrolysis was terminated at that time.

【手続補正9】[Procedure Amendment 9]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】0061[Correction target item name] 0061

【補正方法】変更[Correction method] Change

【補正内容】[Correction content]

【0061】[0061]

【表6】 [Table 6]

【手続補正10】[Procedure Amendment 10]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】0064[Correction target item name] 0064

【補正方法】変更[Correction method] Change

【補正内容】[Correction content]

【0064】滅菌した前記組成の培地10リッターに
酸菌ラクトバシラス・ヘルベティカスを培養し、得られ
た培養液を遠心分離して乳酸菌菌体を回収し、滅菌水に
菌体を懸濁し、遠心分離して乳酸菌菌体を回収する操作
を2回反復して菌体を洗浄し、のち20%の濃度で菌体
を滅菌水に懸濁し、超音波破砕機(ブランソン社製。S
ONIFIER model250)により菌体を破砕
し、凍結乾燥し、乳酸菌由来のエキソペプチダーゼ粉末
約25gを得た。
Milk is added to 10 liters of the sterilized medium having the above composition.
Culturing the acid bacterium Lactobacillus helveticus, centrifuging the obtained culture solution to collect lactic acid bacteria cells, suspending the cells in sterile water, and centrifuging to recover the lactic acid bacteria cells twice. Then, the bacterial cells are washed, and then suspended in sterile water at a concentration of 20%, and then ultrasonically disrupted (manufactured by Branson Co. S.
The microbial cells were crushed by ONIFIER model 250) and freeze-dried to obtain about 25 g of lactic acid bacterium-derived exopeptidase powder.

【手続補正11】[Procedure Amendment 11]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】0066[Correction target item name] 0066

【補正方法】変更[Correction method] Change

【補正内容】[Correction content]

【0066】次に実施例を示して本発明を更に詳述する
が、本発明は以下の実施例に限定されるものではない。
Next, the present invention will be described in more detail by showing examples, but the present invention is not limited to the following examples.

【実施例】 実施例1 純度75%の乳清蛋白質粉末(カリフォルニア・プロテ
イン社製)1kgを、脱イオン水9kgに溶解し、75
℃に15秒間保持して殺菌し、pHを9.0に調整し、
プロテアーゼNアマノ(天野製薬社製)180万PUN
単位(乳清蛋白質1g当たり2400PUN単位)及び
前記参考例1と同一の方法で調製したラクトバシラス
ヘルベティカス菌体破砕物6.8万活性単位(乳清蛋白
質1g当たり90活性単位)を添加し、50℃に保持し
て加水分解し、バイオテックアナライザー(旭化成工業
社製)を用いて経時的に遊離リジンの量を測定し、遊離
リジン量が14%に達した時点で、80℃で6分間加熱
して酵素を失活させ、冷却し、のちクエン酸でpHを
6.0に調整し、分画分子量10,000の限外濾過膜
(日東電工社製)で限外濾過し、乳清蛋白質加水分解物
を5.9%含有する溶液約16kgを得た。
Example 1 1 kg of a whey protein powder having a purity of 75% (manufactured by California Protein Co.) was dissolved in 9 kg of deionized water to prepare 75
Sterilize by holding at ℃ for 15 seconds, adjust pH to 9.0,
Protease N Amano (manufactured by Amano Pharmaceutical Co., Ltd.) 1.8 million PUN
Units (2400 PUN units per gram of whey protein) and Lactobacillus prepared in the same manner as in Reference Example 1 above.
Helveticus cell disruption product (60,000 activity units (90 activity units per 1 g of whey protein)) was added, and the mixture was kept at 50 ° C to hydrolyze and then biotech analyzer (manufactured by Asahi Kasei Kogyo Co., Ltd.) was used. The amount of free lysine was measured, and when the amount of free lysine reached 14%, the enzyme was inactivated by heating at 80 ° C. for 6 minutes, cooled, and then the pH was adjusted to 6.0 with citric acid, Ultrafiltration was performed with an ultrafiltration membrane having a molecular weight cut-off of 10,000 (manufactured by Nitto Denko Corporation) to obtain about 16 kg of a solution containing 5.9% whey protein hydrolyzate.

【手続補正12】[Procedure Amendment 12]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】0069[Correction target item name] 0069

【補正方法】変更[Correction method] Change

【補正内容】[Correction content]

【0069】実施例2 純度85%の乳清蛋白質粉末(デンマーク・プロテイン
社製)1kgを、脱イオン水19kgに溶解し、pHを
10に調整し、市販のトリプシン(ノボノルディスク社
製)を11万PUN単位(乳清蛋白質1g当たり130
PUN単位)、プロテアーゼNアマノ(天野製薬社製)
180万PUN単位(乳清蛋白質1g当たり2100P
UN単位)及び前記参考例1と同様の方法で調製した
クトバシラス・プルガリカス菌体破砕物5.1万活性単
位(乳清蛋白質1g当たり60活性単位)を添加し、4
0℃で加水分解し、バイオテックアナライザー(旭化成
工業社製)を用いて経時的に遊離リジンの量を測定し、
遊離リジン量が17%に達した時点で、130℃で2秒
間加熱して酵素を失活させ、冷却し、のちクエン酸でp
Hを6.5に調整し、分画分子量3,000の限外濾過
膜(旭化成工業社製)で限外濾過し、濃縮し、噴霧乾燥
し、粉末状の乳清蛋白質加水分解物約800gを得た。
Example 2 1 kg of 85% pure whey protein powder (manufactured by Denmark Protein Co.) was dissolved in 19 kg of deionized water to adjust the pH to 10, and commercially available trypsin (manufactured by Novo Nordisk Co.) was used. 110,000 PUN units (130 per gram of whey protein
PUN unit), Protease N Amano (Amano Pharmaceutical Co., Ltd.)
1.8 million PUN units (2100P per gram of whey protein)
La prepared by UN units) and Reference Example 1 In the same manner as
C. Bacillus purgaricus crushed cells 51,000 activity units (60 activity units per 1 g of whey protein) were added, and 4
It is hydrolyzed at 0 ° C., and the amount of free lysine is measured with time using a Biotech analyzer (manufactured by Asahi Kasei Corporation).
When the amount of free lysine reached 17%, the enzyme was inactivated by heating at 130 ° C. for 2 seconds, cooled, and then added with citric acid.
H was adjusted to 6.5, ultrafiltered with an ultrafiltration membrane having a molecular weight cut off of 3,000 (manufactured by Asahi Chemical Industry Co., Ltd.), concentrated, spray-dried, and powdered whey protein hydrolyzate about 800 g Got

【手続補正13】[Procedure Amendment 13]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】0071[Correction target item name] 0071

【補正方法】変更[Correction method] Change

【補正内容】[Correction content]

【0071】実施例3 純度90%の乳清蛋白質粉末(バイオポール社製)1k
gを、脱イオン水19kgに溶解し、75℃に15秒間
保持して殺菌し、pHを8.0に調整し、市販のパパイ
ン(天野製薬社製)を10万PUN単位(乳清蛋白質1
g当たり110PUN単位)、ニュートラーゼ(ノボノ
ルディスク社製)220万PUN単位(乳清蛋白質1g
当たり2400PUN単位)及び前記参考例1と同様の
方法で調整したビフィドバクテリウム・ブレーベ菌体破
砕物9万活性単位(乳清蛋白質1g当たり100活性単
位)を添加し、50℃に保持して加水分解し、バイオテ
ックアナライザー(旭化成工業社製)を用いて経時的に
遊離リジンの量を測定し、遊離リジン量が20%に達し
た時点で、85℃で15分間加熱して酵素を失活させ、
冷却し、のちクエン酸でpHを7.0に調整し、分画分
子量10,000の限外濾過膜(日東電工社製)で限外
濾過し、濃縮し、噴霧乾燥し、粉末状の乳清蛋白質加水
分解物約800gを得た。
Example 3 Whey protein powder having a purity of 90% (manufactured by Biopol) 1k
g was dissolved in 19 kg of deionized water, sterilized by holding at 75 ° C. for 15 seconds, the pH was adjusted to 8.0, and commercially available papain (manufactured by Amano Pharmaceutical Co., Ltd.) was added to 100,000 PUN units (whey protein 1
110 PUN units per g), Neutrase (Novo Nordisk) 2.2 million PUN units (whey protein 1 g)
Was added per 2400PUN units) and the Reference Example 1 bi prepared in the same manner as Bifidobacterium breve disrupted cells 90,000 activity units (whey protein 1g per 100 activity units), and held at 50 ° C. After hydrolysis, the amount of free lysine was measured with time using a Biotech analyzer (manufactured by Asahi Kasei Co., Ltd.), and when the amount of free lysine reached 20%, it was heated at 85 ° C for 15 minutes to lose the enzyme. Let it live
After cooling, the pH is adjusted to 7.0 with citric acid, ultrafiltered with an ultrafiltration membrane with a molecular weight cut-off of 10,000 (manufactured by Nitto Denko), concentrated, spray-dried and powdered milk. About 800 g of clear protein hydrolyzate was obtained.

【手続補正14】[Procedure Amendment 14]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】0073[Correction target item name] 0073

【補正方法】変更[Correction method] Change

【補正内容】[Correction content]

【0073】実施例4 純度70%の乳清蛋白質粉末(ミライ社製)1kgを、
脱イオン水5.7kgに溶解し、pHを9.0に調整
し、ビオプラーゼ6.0S(長瀬生化学工業社製)16
0万PUN単位(乳清蛋白質1g当たり2000PUN
単位)及び前記参考例1と同様の方法で調製したストレ
プトコッカス・ラクチス菌体破砕物6.3万活性単位
(乳清蛋白質1g当たり90活性単位)を添加し、45
℃で加水分解し、バイオテックアナライザー(旭化成工
業社製)を用いて経時的に遊離リジンの量を測定し、遊
離リジン量が19%に達した時点で、130℃で2秒間
加熱して酵素を失活させ、冷却し、のちクエン酸でpH
を7.0に調整し、分画分子量10,000の限外濾過
膜(旭化成社製)で限外濾過し、乳清蛋白質加水分解物
を8.4%含有する溶液約11kgを得た。
Example 4 1 kg of whey protein powder having a purity of 70% (manufactured by Mirai Co.)
Dissolved in 5.7 kg of deionized water, adjusted the pH to 9.0, and used bioprase 6.0S (Nagase Seikagaku Corporation) 16
0,000 PUN units (2000 PUN per 1 g of whey protein)
Units) and 63,000 active units of Streptococcus lactis cell disrupted product (90 active units per 1 g of whey protein) prepared in the same manner as in Reference Example 1 above.
After hydrolyzing at ℃, the amount of free lysine was measured with time using a Biotech analyzer (manufactured by Asahi Kasei Co., Ltd.), and when the amount of free lysine reached 19%, the mixture was heated at 130 ° C. for 2 seconds and the enzyme was added. Deactivate, cool, and then pH with citric acid
Was adjusted to 7.0 and subjected to ultrafiltration with an ultrafiltration membrane having a molecular weight cut off of 10,000 (manufactured by Asahi Kasei) to obtain about 11 kg of a solution containing 8.4% whey protein hydrolyzate.

【手続補正15】[Procedure Amendment 15]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】0075[Correction target item name] 0075

【補正方法】変更[Correction method] Change

【補正内容】[Correction content]

【0075】実施例5 純度80%の乳清蛋白質粉末(ニュージーランド・デー
リー・ボード製)1kgを、脱イオン水12.3kgに
溶解し、75℃に15秒間保持して殺菌し、pHを8.
5に調整し、市販のパパイン(天野製薬社製)を8万P
UN単位(乳清蛋白質1g当たり100PUN単位)、
ビオプラーゼ(長瀬生化学工業社製)220万PUN単
位(乳清蛋白質1g当たり2700PUN単位)及び前
記参考例1と同様の方法で調製したストレプトコッカス
・クレモリス菌体破砕物5.6万活性単位(乳清蛋白質
1g当たり70活性単位)を添加し、pHを6.5に保
持して55℃で加水分解し、バイオテックアナライザー
(旭化成工業社製)を用いて経時的に遊離リジンの量を
測定し、遊離リジン量が17%に達した時点で、90℃
で5分間加熱して酵素を失活させ、冷却し、のちクエン
酸でpHを5.5に調整し、分画分子量10,000の
限外濾過膜(日東電工社製)で限外濾過し、濃縮し、噴
霧乾燥し、粉末状の乳清蛋白質加水分解物約800gを
得た。
Example 5 1 kg of whey protein powder having a purity of 80% (manufactured by New Zealand Daily Board) was dissolved in 12.3 kg of deionized water and kept at 75 ° C. for 15 seconds for sterilization to adjust the pH to 8.
Adjusted to 5, commercial papain (Amano Pharmaceutical Co., Ltd.) 80,000P
UN units (100 PUN units per 1 g of whey protein),
Biopulase (manufactured by Nagase Seikagaku Corporation) 2.2 million PUN units (2700 PUN units per 1 g of whey protein) and Streptococcus cremoris cell disruption product 56,000 active units (whey) prepared in the same manner as in Reference Example 1 above. (70 activity units per 1 g of protein) was added, the pH was kept at 6.5, hydrolysis was carried out at 55 ° C., and the amount of free lysine was measured with time using a Biotech Analyzer (Asahi Kasei Co., Ltd.). When the amount of free lysine reaches 17%, 90 ° C
The mixture is heated for 5 minutes to inactivate the enzyme, cooled, then adjusted to pH 5.5 with citric acid, and ultrafiltered with an ultrafiltration membrane (Nitto Denko) with a molecular weight cutoff of 10,000. After concentrating and spray-drying, about 800 g of powdery whey protein hydrolyzate was obtained.

【手続補正16】[Procedure Amendment 16]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】0077[Correction target item name] 0077

【補正方法】変更[Correction method] Change

【補正内容】[Correction content]

【0077】実施例6 純度70%の乳清蛋白質粉末(カリフォルニア・プロテ
イン社製)1kgを、脱イオン水7kgに溶解し、pH
を8.0に調整し、ブロメライン(天野製薬社製)35
万PUN単位(乳清蛋白質1g当たり500PUN単
位)、ニュートラーゼ(ノボノルディスク社製)230
万PUN単位(乳清蛋白質1g当たり3300PUN単
位)及び前記参考例1と同様の方法で調製したラクトバ
シラス・ブルガリカス菌体破砕物5.6万活性単位(乳
清蛋白質1g当たり80活性単位)を添加し、47℃で
加水分解し、バイオテックアナライザー(旭化成工業社
製)を用いて経時的に遊離リジンの量を測定し、遊離リ
ジン量が17%に達した時点で、85℃で15分間加熱
して酵素を失活させ、冷却し、のちクエン酸でpHを
5.5に調整し、分画分子量10,000の限外瀘過膜
(日東電工社製)で限外濾過し、濃縮し、噴霧乾燥し、
粉末状の乳清蛋白質加水分解物約800gを得た。
Example 6 1 kg of whey protein powder having a purity of 70% (California Protein Co., Ltd.) was dissolved in 7 kg of deionized water to adjust the pH.
Was adjusted to 8.0 and bromelain (manufactured by Amano Pharmaceutical Co., Ltd.) 35
10,000 PUN units (500 PUN units per 1 g of whey protein), Neutrase (Novo Nordisk) 230
10,000 PUN units (3300 PUN units per 1 g of whey protein) and lactova prepared in the same manner as in Reference Example 1
Shirasu bulgaricus cell disruption product (56,000 activity units (80 activity units per 1 g of whey protein)) was added, hydrolyzed at 47 ° C, and time-lapsed using a Biotech analyzer (Asahi Kasei Co., Ltd.). The amount of free lysine was measured, and when the amount of free lysine reached 17%, it was heated at 85 ° C for 15 minutes to inactivate the enzyme, cooled, and then adjusted to pH 5.5 with citric acid, Ultrafiltration membrane with a molecular weight cut off of 10,000 (manufactured by Nitto Denko), ultrafiltration, concentration, spray drying,
About 800 g of powdery whey protein hydrolyzate was obtained.

【手続補正17】[Procedure Amendment 17]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】0079[Correction target item name] 0079

【補正方法】変更[Correction method] Change

【補正内容】[Correction content]

【0079】実施例7 純度80%の乳清蛋白質粉末(デンマーク・プロテイン
社製)1kgを、脱イオン水9kgに溶解し、pHを
7.5に調整し、市販のニュートラーゼ(ノボノルディ
スク社製)を160万PUN単位(乳清蛋白質1g当た
り2000PUN単位)及び前記参考例1と同様の方法
調製したビフィドバクテリウム・ブレーベ菌体破砕物
2.8万活性単位(乳清蛋白質1g当たり35活性単
位)を添加し、pH7.5に保持して45℃で加水分解
し、バイオテックアナライザー(旭化成工業社製)を用
いて経時的に遊離リジンの量を測定し、遊離リジン量が
12%に達した時点で、90℃で20分間加熱して酵素
を失活させ、冷却し、のちクエン酸でpHを7.0に調
整し、分画分子量3,000の限外濾過膜(旭化成社
製)で限外濾過し、濃縮し、噴霧乾燥し、粉末状の乳清
蛋白質加水分解物約800gを得た。
Example 7 1 kg of whey protein powder having a purity of 80% (manufactured by Protein Co., Denmark) was dissolved in 9 kg of deionized water to adjust the pH to 7.5, and a commercially available Neutrase (Novo Nordisk Co.) was used. Manufactured) by 1.6 million PUN units (2000 PUN units per 1 g of whey protein) and 28,000 active units of crushed Bifidobacterium breve cells prepared by the same method as in Reference Example 1 (per 1 g of whey protein) 35 activity units) was added, and the mixture was kept at pH 7.5 and hydrolyzed at 45 ° C., and the amount of free lysine was measured with time using a Biotech analyzer (Asahi Kasei Co., Ltd.). %, The enzyme was inactivated by heating at 90 ° C. for 20 minutes, cooled, and then the pH was adjusted to 7.0 with citric acid, and an ultrafiltration membrane with a molecular weight cutoff of 3,000 (Asahi Kasei Company ), Ultrafiltrate, concentrate and spray dry to obtain about 800 g of powdery whey protein hydrolyzate.

───────────────────────────────────────────────────── フロントページの続き (72)発明者 磯村 奈生子 神奈川県座間市東原5−1−83 森永乳業 株式会社栄養科学研究所内 (72)発明者 赤染 陽子 神奈川県座間市東原5−1−83 森永乳業 株式会社栄養科学研究所内 (72)発明者 越智 浩 神奈川県座間市東原5−1−83 森永乳業 株式会社栄養科学研究所内 (72)発明者 河本 美穂子 神奈川県座間市東原5−1−83 森永乳業 株式会社栄養科学研究所内 ─────────────────────────────────────────────────── ─── Continuation of the front page (72) Inventor Naoko Isomura 5-1-83 Higashihara, Zama City, Kanagawa Prefecture Morinaga Milk Industry Co., Ltd. (72) Inventor Yoko Azome 5-1-83 Higashihara, Zama City, Kanagawa Prefecture Morinaga Dairy Industry Co., Ltd., Institute of Nutrition Science (72) Inventor Hiroshi Ochi 5-1-83 Higashihara, Zama City, Kanagawa Prefecture Morinaga Dairy Co., Ltd., Institute of Nutrition Science (72) Mihoko Kawamoto 5-1-83, Higashihara, Zama City, Kanagawa Prefecture Morinaga Dairy Co., Ltd. Nutritional Research Institute

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】 純度が少なくとも70%(重量)の乳清
蛋白質の加水分解物であって、次のa)〜h)の理化学
的性質; a)分子量5,000〜10,000ダルトンの画分
が、全加水分解物の1%(重量)未満であること、 b)抗乳清蛋白質血清を用いたエライザ抑制試験法によ
り測定した抗原残存活性が10-5以下であること、 c)加水分解物の全アミノ酸の量に対する遊離アミノ酸
の量の割合が10〜15%(重量)であること、 d)乳清蛋白質に含まれる全リジンの量に対する遊離リ
ジンの量の割合が12〜20%(重量)であること、 e)アンモニア含量が0.2%(重量)以下であるこ
と、 f)10%(重量)溶液を1cmのセル、540nmで
測定した透過率が98%以上であること、 g)pH4〜7の5%(重量)溶液を120℃で10分
間加熱して沈殿を生じないこと、及び h)抗酸化活性を有すること、を有することを特徴とす
る風味良好な乳清蛋白加水分解物。
1. A hydrolyzate of whey protein having a purity of at least 70% (by weight), which has the following physicochemical properties of a) to h): a) a molecular weight of 5,000 to 10,000 Daltons. The content is less than 1% (by weight) of the total hydrolyzate, b) the residual antigen activity measured by the ELISA inhibition test method using anti-whey protein serum is 10 −5 or less, and c) the water. The ratio of the amount of free amino acid to the total amount of amino acid in the decomposed product is 10 to 15% (by weight), and d) the ratio of the amount of free lysine to the amount of total lysine contained in whey protein is 12 to 20%. (Weight), e) Ammonia content is 0.2% (weight) or less, f) 10% (weight) solution is 1 cm cell, and the transmittance measured at 540 nm is 98% or more. , G) 5% (by weight) solution of pH 4-7 It does not cause heat to precipitate at 120 ° C. 10 minutes, and h) to have antioxidant activity, characterized by having a good flavor whey protein hydrolyzate.
【請求項2】 純度が少なくとも70%(重量)の乳清
蛋白質を15%(重量)以下の濃度で水に溶解し、該水
溶液のpHを7.5〜10に調整し、該水溶液にバシラ
ス・サチリス(Bacillus subtilis) 由来のエンドペプチ
ダーゼ及び乳酸菌由来のエキソペプチダーゼの2種類の
蛋白分解酵素を添加して加水分解を開始し、分解液中の
遊離リジン量を経時的に測定し、出発原料である乳清蛋
白質に含まれる全リジンの量に対する遊離リジンの量の
割合が12〜20%(重量)の範囲で加水分解を停止
し、限外濾過して分子量10,000ダルトン以上の画
分を完全に除去することを特徴とする風味良好な乳清蛋
白加水分解物の製造法。
2. Whey protein having a purity of at least 70% (weight) is dissolved in water at a concentration of 15% (weight) or less, the pH of the aqueous solution is adjusted to 7.5 to 10, and the aqueous solution is Bacillus.・ Two types of proteolytic enzymes, endopeptidase derived from Bacillus subtilis and exopeptidase derived from lactic acid bacteria, are added to initiate hydrolysis, and the amount of free lysine in the degradation solution is measured over time to obtain the starting material. Hydrolysis is stopped when the ratio of the amount of free lysine to the amount of total lysine contained in a certain whey protein is in the range of 12 to 20% (by weight), and ultrafiltration is performed to obtain a fraction having a molecular weight of 10,000 daltons or more. A method for producing a whey protein hydrolyzate having a good flavor, which is characterized by being completely removed.
JP6274303A 1994-10-14 1994-10-14 Savory whey protein hydrolyzate and method for producing the same Expired - Fee Related JP2959747B2 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
JP6274303A JP2959747B2 (en) 1994-10-14 1994-10-14 Savory whey protein hydrolyzate and method for producing the same
PCT/JP1995/002109 WO1996011584A1 (en) 1994-10-14 1995-10-13 Peptide mixture and products thereof
US08/817,095 US5952193A (en) 1994-10-14 1995-10-13 Peptide mixture and products thereof
AU36738/95A AU692612B2 (en) 1994-10-14 1995-10-13 Peptide mixture and products thereof
DE69523791T DE69523791T2 (en) 1994-10-14 1995-10-13 PEPTIDE MIXTURE AND PRODUCTS THEREOF
NZ294046A NZ294046A (en) 1994-10-14 1995-10-13 A palatable whey protein hydrolysate having antioxidant activity
CA002202633A CA2202633C (en) 1994-10-14 1995-10-13 Peptide mixture and products thereof
EP95934302A EP0799577B1 (en) 1994-10-14 1995-10-13 Peptide mixture and products thereof
DK95934302T DK0799577T3 (en) 1994-10-14 1995-10-13 Peptide Mixture and Products thereof
AU63603/98A AU701507B2 (en) 1994-10-14 1998-04-24 Peptide mixture and products thereof
US09/316,957 US6395508B1 (en) 1994-10-14 1999-05-24 Peptide mixture and products thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6274303A JP2959747B2 (en) 1994-10-14 1994-10-14 Savory whey protein hydrolyzate and method for producing the same

Publications (2)

Publication Number Publication Date
JPH08112063A true JPH08112063A (en) 1996-05-07
JP2959747B2 JP2959747B2 (en) 1999-10-06

Family

ID=17539769

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6274303A Expired - Fee Related JP2959747B2 (en) 1994-10-14 1994-10-14 Savory whey protein hydrolyzate and method for producing the same

Country Status (1)

Country Link
JP (1) JP2959747B2 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006075006A (en) * 2004-09-07 2006-03-23 En Otsuka Pharmaceutical Co Ltd Excellently flavored amino acid/peptide mixture, and method for producing the same
JP2008260761A (en) * 2007-03-16 2008-10-30 Up Well:Kk Milk component hydrolyzate
JP2009521955A (en) * 2006-01-04 2009-06-11 レプリノ フーズ カンパニー Protein hydrolyzate and method of making the same
WO2010005012A1 (en) * 2008-07-09 2010-01-14 株式会社アップウェル Apolactoferrin-containing composition
JP2010527590A (en) * 2007-05-18 2010-08-19 ミード ジョンソン ニュートリション カンパニー Acidic liquid breastfeeding supplements

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006075006A (en) * 2004-09-07 2006-03-23 En Otsuka Pharmaceutical Co Ltd Excellently flavored amino acid/peptide mixture, and method for producing the same
JP4619730B2 (en) * 2004-09-07 2011-01-26 イーエヌ大塚製薬株式会社 Amino acid / peptide mixture with excellent flavor and method for producing the same
JP2009521955A (en) * 2006-01-04 2009-06-11 レプリノ フーズ カンパニー Protein hydrolyzate and method of making the same
JP2008260761A (en) * 2007-03-16 2008-10-30 Up Well:Kk Milk component hydrolyzate
JP2010527590A (en) * 2007-05-18 2010-08-19 ミード ジョンソン ニュートリション カンパニー Acidic liquid breastfeeding supplements
WO2010005012A1 (en) * 2008-07-09 2010-01-14 株式会社アップウェル Apolactoferrin-containing composition
JP5712429B2 (en) * 2008-07-09 2015-05-07 株式会社アップウェル Apolactoferrin-containing composition

Also Published As

Publication number Publication date
JP2959747B2 (en) 1999-10-06

Similar Documents

Publication Publication Date Title
US6395508B1 (en) Peptide mixture and products thereof
US7648721B2 (en) Hydrolyzed milk proteins
US5112812A (en) Peptide preparation, a process for producing it and use of the peptide preparation
AU2009332369B2 (en) Muscle-building agent
CLEGG et al. Dietary enzymic hydrolysates of protein with reduced bitterness
JPS5854786B2 (en) Method for producing protein hydrolyzate from whey protein
JP2959747B2 (en) Savory whey protein hydrolyzate and method for producing the same
JP3226695B2 (en) Process for producing whey protein hydrolyzate excellent in emulsifiability and heat stability, and antiallergic formula using the whey protein hydrolyzate
JP3386635B2 (en) Casein hydrolyzate
JPH11243866A (en) Casein hydrolyzate and its production
JP3222638B2 (en) Oligopeptide mixture and method for producing the same
JPH04248959A (en) Oligopeptide mixture and its production
JP3061649B2 (en) Antiallergic formula
JP3437738B2 (en) Method for producing protein hydrolyzate with reduced odor
JP2631202B2 (en) Peptide production method
JP3383461B2 (en) Casein hydrolyzate and method for producing the same
JP3682994B2 (en) Process for producing peptide mixtures with low phenylalanine content
JP3636322B2 (en) Whey protein hydrolyzate and method for producing the same
JP2000001500A (en) Whey protein peptide, its production and nutritive composition containing the same
JP2020068668A (en) Milk protein hydrolyzate and method of producing the same
AU701507B2 (en) Peptide mixture and products thereof
JPH053753A (en) Milk composition for food allergy
JPH05344847A (en) Low antigenic decomposed protein free from disagreeable taste and its production
JPH0622446B2 (en) Method for producing easily soluble milk protein hydrolyzate having no unpleasant taste
JPS58158138A (en) Production of protein suitable for enzymatic hydrolysis

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080730

Year of fee payment: 9

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080730

Year of fee payment: 9

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090730

Year of fee payment: 10

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090730

Year of fee payment: 10

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100730

Year of fee payment: 11

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110730

Year of fee payment: 12

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110730

Year of fee payment: 12

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120730

Year of fee payment: 13

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120730

Year of fee payment: 13

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130730

Year of fee payment: 14

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees